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1 INTRODUCTION 
  
“Graphene may be the most remarkable substance ever discovered. But what’s 
it for?”- John Colapinto, a staff writer at The New Yorker. 
After Andre Geim, a physics professor at the University of Manchester, and a 
colleague Kostya Novoselov discovered an unusual new material called graphene; 
he wrote a three-page paper describing their discoveries. It was twice rejected by the 
journal Nature, where reviewers stated that isolating a stable, two-dimensional 
material is impossible and that it was not a sufficient scientific advance. Indeed, in 
2004 the paper, “Electric Field Effect in Atomically Thin Carbon Films” was 
published in Science, and it astonished scientists - science fiction had become 
reality.  
 Graphene, the two-dimensional sp2-hybridised carbon, is currently the most 
intensively studied material. This single-atom-thick sheet of carbon atoms situated 
in a honeycomb pattern is the world’s strongest and thinnest material, also being an 
excellent conductor of both electricity and heat. From the application viewpoint, this 
two-dimensional material is considered to be more promising than other 
nanostructured carbon allotropes (1-dimensional nanotubes or 0-dimensional 
fullerenes) (Georgakilas et al., 2012).  
The intensive research about graphene in recent years is promising a 
revolution in chemical and electrical engineering. Chemical Engineering of 
graphene-based materials applies physical sciences (nanographene for improving 
drilling fluids performance, integrated graphene dispersion to create high 
performance fluids, graphene-enhanced composites added to rubber to increase its 
strength, conductivity and impermeability, etc.) and life sciences. The bio-
applications of graphene and its derivatives is due to many desirable properties, such 
as a high specific surface area (2,630 m2/g), mechanical strength (Young’s modulus, 
~1,100 GPa), electrical conductivity (200,000 cm2 V-1 s-1), thermal conductivity 
(~5,000 W/m/K) of graphene and bio-compatibility, low cost, scalable production 
and facile biological/chemical functionalisation of GO (Jiang, 2011; Guo and Dong, 
2011). Graphene oxide easily combines with many other nanoscale materials leading 
to new applications in the fields of drug delivery, cancer therapeutics, tissue 
engineering, diagnostics and bioimaging (Wu, An and Hulme, 2015).  
The critical issue to be resolved before further applications of graphene in 
nanomedicine is the potential short and long-term toxicity of this new nanomaterial. 
Many previous investigations have shown GO and its hybrid structures to induce 
low cell toxicity, but reports remain conflicting. A number of groups have 
performed experiments to explore the suitability in nanomedicine and effects of 
graphene, but this question still is not properly understood and needs further 
investigations. 
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The aim of the thesis is the synthesis of new hybrid nanostructures by 
functionalisation of graphene/graphene oxide with porphyrins and doxorubicin, also 
the investigation and evaluation of it as a possible drug delivery platform in 
nanomedicine. 
Objectives of the thesis  
1) Development and optimisation of methods for the functionalisation of 
graphene/graphene oxide nanoparticles with organic molecules and characterisation 
of physicochemical properties of functionalised structures. 
2) Development and optimisation of methods to synthesise new hybrid 
macromolecules using graphene oxide with organic molecules and characterisation 
of synthesised macromolecules. 
3) Analysis of graphene oxide nanoparticles interaction with lipid membranes, 
as a model for nanoparticles interaction with bio-membranes. 
4) Determining the mechanism of graphene oxide transfer into the living cell 
and the possible toxicity of graphene oxide in different cell lines. 
5) Determining the toxicity of functionalised graphene oxide with doxorubicin 
for cancer cells. 
Scientific novelty 
During this study, the novel methodology of graphene oxide functionalisation 
with hematoporphyrin (GO-HP) by chemical covalent binding was designed. New 
graphene-based hybrid nanostructures (GO-HP) and macromolecules (GO/TPyP) 
were synthesised. The interaction of GO, ZnO and TiO2 nanoparticles with lipid 
membranes was performed and the influence of nanoparticles on lipid membranes 
dynamics and membranes disruption was evaluated. 
For the first time, the impact of graphene oxide and graphene oxide with 
protein “corona” on the viability of different cell lines (Chinese hamster ovary and 
mouse hepatoma MH-22A cells) and the impact of functionalised graphene oxide 
with doxorubicin on the viability of mouse hepatoma MH-22A cells were evaluated.  
Defended statements 
1. The synthesised graphene and porphyrin structures could be interconnected 
through non-covalent interactions and in the case of grapheme oxide and porphyrin, 
through both non-covalent interactions and covalent bonds. 
2. Due to the different physicochemical properties of GO, ZnO and TiO2 (e.g. 
size of nanoparticles, shape, zeta potential) they exhibit different mechanisms of 
interaction with synthesised lipid membranes (formed of DOPS and DOPC 
phospholipids). 
3. MH-22A cancerous cells are better at absorbing graphene oxide 
nanoparticles than healthy CHO cells. 
4. Functionalisation of GO with doxorubicin enhances the anticancer effect of 
doxorubicin. The concentration of the toxic anticancer drug doxorubicin can be 
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reduced more than 10,000 times by using a hybrid compound of graphene oxide and 
doxorubicin. 
Outline of the dissertation 
The dissertation consists of an introduction (section I), literature overview 
(section II), materials and research methodology (section III), experimental part 
results and discussion (section IV), conclusions (section V), list of references 
(section 6) and the list of publications and conferences. The material of the 
dissertation is presented in 133 pages, including 76 figures and 10 tables. 
Approbation of the research results 
The results of this thesis are presented in four (4) publications corresponding 
to the list of the Web of Science database by Thomson Reuters; one (1) publication 
published in the journal referred to in international databases and presented at ten 
(10) international conferences (3 invited presentations) and 2 seminars. 
 
Practical significance of the dissertation. Part of the results obtained during 
the preparation of the dissertation were used in the successfully implemented project 
“Nanoscopic investigation of structural transformations of proteins at the nano-bio-
interfaces” (NanoProt, 2013-2015).  
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2 REVIEW OF THE LITERATURE 
2.1 Nanotechnology in medicine 
The medical application of nanotechnology (nanomedicine) (Andrew, 1999) is 
the medical applications of nanomaterials/nanoparticles and biological devices, to 
nanoelectronic biosensors and biological machines. Current problems for 
nanomedicine involve understanding the issues related to toxicity and the 
environmental impact of nanoparticles. Carbon based nanoparticles are promising 
due their blood biocompatibility with pyrolytic carbon heart valves, with good 
adherence of endothelial cells and minimal adherence and activation of platelets 
(Haubold, 1983). The dense and metastable form of amorphous carbon- diamond-
like carbon is desirable for biomedical applications due its extreme hardness, low 
coefficient of friction, chemical inertness and good corrosion and wear resistance 
(Sheeja, Tay, Nung, 2004). The biocompatibility of diamond-like carbon was proven 
for orthopaedic and cardiovascular applications, also no inflammatory response from 
macrophage cells in vitro (Linder, Pinkowski and Aepfelbacher, 2002) and no 
cytotoxic effects on fibroblasts or osteoblast cells have been observed. Among the 
graphene derivatives, graphene oxide has been widely explored for in vitro and in 
vivo drug delivery and imaging, (Pan, Sahoo and Li, 2012; Hong et al., 2012) and its 
good biocompatibility was supported by some studies: (Yang et al., 2012; 
Sasidharan et al., 2012). Current carbon-based biomaterials demonstrate excellent 
biocompatibility and it is hoped that the unique properties of graphene/graphene 
oxide can be safely and effectively exploited in biomedicine. 
Although the biocompatibility of GO is inconclusive (Snitka, 2015), the 
different experimental conditions and GO characteristics, such as GO size, dose, 
exposure methods and surface properties, may be the reasons for the incompatibility 
(Yang et al., 2012; Chang et al., 2011). Therefore, more studies are needed to 
understand the conditions of the safe use of graphene related nanoparticles.  
2.2 Carbon-based materials 
Carbon is the fourth most abundant element in the universe and is the Materia 
prima for all life (Neto et al., 2009; Suess and Urey, 1956). This gives carbon a 
central role in organic chemistry as well as being an important element in inorganic 
and organic chemistry, materials science and biomedicine. The carbon atom, with its 
six electrons, is tetravalent, having four of the electrons available for chemical 
bonding. Because of the flexibility of its bonding, carbon has several different 
allotropes with a large variety of physical properties. The main forms of elemental 
carbon are diamond and graphite. Under ambient conditions graphite is the stable 
phase, while under the application of high pressure and high temperature a 
transformation to the diamond structure occurs (Dresselhaus, Eklund, 1996; Hagg et 
al., 1988; Steinbeck et al. 1985) (see Fig. 2.1.).  
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Fig. 2.1.The phase diagram for diamond and graphite (Bundy, 1979) 
Moreover, graphite is a soft material due to its layered structure, while 
diamond is one of the hardest materials observed. The properties of carbon vary 
depending on the degree of crystallinity as well as ratio between sp2 and sp3 carbon 
atoms in the material. Recently, research on nanoscale objects and nanostructured 
materials has been expanded. Nanomaterials of carbon, and especially graphitic 
nanomaterials, have cause huge interest in the last decade because of the discovery 
of several new nanoscale graphitic materials with unique properties (Iljima et al., 
1991; Novoselov et al., 2004; Sano et al., 2001).  
Different types of carbon nanomaterials, including fullerenes, graphene and 
carbon nanotubes, have many technological advantages such as easy modification by 
functional groups, high carrier capacity, incorporating both hydrophilic and 
hydrophobic substances, and high chemical stability, and the possibility of being 
used for many applications is becoming more popular. A wide variety of carbon-
based materials are available, such as nanoparticles, nanodiamonds, fullerenes, 
nanotubes, etc. (Table 2.1), which have been used in analytical applications 
(Săndulescu et al., 2015). The sp2-bonded carbon atoms configuration is responsible 
for the development of strong van der Waals forces that significantly prevent the 
solubility and dispersion of carbon-based nanoparticles. To avoid these problems, 
different methods have been proposed (Zhao, Chen and Xie, 2006; Wooten and 
Gorksi, 2010; Bose, Khare and Moldenaers, 2010), such as the addition of polar 
groups (oxygen, hydroxyl, phenyl, etc.). The stability, mechanical and electrical 
properties could also be affected by the surface defects of carbon nanostructures 
(Soetedjo, Mora and Garcia, 2010; Masheter et al., 2007). 
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Table 2.1. Carbon-based materials  
The main forms of carbon: 
Amorphous carbon Graphite Diamond 
   
The carbon nanomaterials: 
Graphene Nanodiamonds Nano-onions 
 
 
  
Nano-peapods Nanofibres Nanorings 
 
  
Fullerenes Fullerites Carbon nanotubes 
C540 C60 MWCNT SWCNT 
  
 
2.2.1 Graphene 
The stacks of graphene, the basic building blocks of graphite, are held together 
by weak van der Waal forces. Graphene is a material that proposes great prospects 
for the future of engineering and analytical chemistry, consisting of one-atom-thick 
sheets that provide a specific surface area (of 2,630 m2/g). Graphene based 
architectures were initially foreseen as an abnormal case keeping in mind their 
different nature in respect of biomolecules or cellular substructures. Graphene has a 
high mechanical strength, elasticity and high thermal conductivity (Pumera et al., 
2010; Geim and Novoselov 2007; Neto et al., 2009), but also, like other carbon-
based materials, presents a disadvantage: its poor dispersion in aqueous medium. 
Indeed, the stable dispersions of graphene sheets have been achieved using 
alkylamines and hydrophilic carboxyl groups, amphiphilic polymers or other 
dispersing agents (Bustos-Ramirez et al., 2013). Also, graphene can be used as an 
active element in many applications either pristine and/or functionalised by a wide 
range of molecules (Huang et al., 2011; Bai, Li and Shi, 2011). The functionalisation 
of graphene is important to controllably coordinate its properties using both covalent 
                  20 
 
and non-covalent approaches (Georgakilas et al., 2012; Sreeprasad and Berry, 2013; 
Huang et al. 2012). The functionalisation of graphene is one of the ways for 
improving its dispersion. Therefore, graphene oxide, a graphite derivative with 
hydroxyl, epoxy and carboxyl groups covalently attached to its layers, shows a 
better dispersibility in some solvents than graphene. 
There is a wide variety of methods for graphene fabrication. The first method, 
published in 2004 (Novoselov et al., 2004), is the mechanical exfoliation of small 
patches of highly ordered pyrolytic graphite. Afterwards, other fabrication methods 
have been developed: unzipping MWCNT to form graphene ribbons (Bai and 
Huang, 2010); substrate-independent methods using micro-moulding inside a 
capillary (He et al., 2010) and spray deposition of graphene oxide-hydrazine 
dispersions (Pham et al., 2010). 
The possible industrial applications of graphene are very wide. It is known that 
graphene could be used in bendable LCD screens, bendable watches and 
smartphones, and sensors in textile; graphene could replace carbon black to 
strengthen rubbers and tyres; graphene reinforcement in polymers and polymer 
composites to optimise the mechanical properties (stiffness, strength) and thermal 
conductivity, etc. 
2.2.2 Graphene functionalisation 
Since 2004 a major focus of experimental research has been concentrated on 
the development of new synthetic routes (see Fig. 2.2, the rate of growth in the 
number of studies carried out on graphene functionalisation in the world) enabling 
an effective production and functionalisation of well-defined graphene sheets.  
 
Fig. 2.2. Annual number of graphene functionalisation-related publications. Statistics 
obtained according to the Web of Science data 
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Graphene sheets can be chemically modified using either the covalent or non-
covalent method. 
A covalent bond is a region of relatively high electron density between nuclei 
which arises at least partly from the sharing of electrons and gives rise to an 
attractive force and characteristic internuclear distance. For many molecules, the 
sharing of electrons allows each atom to attain the equivalent of a full outer shell, 
corresponding to a stable electronic configuration. Covalent bonding includes many 
kinds of interactions, including σ-bonding, π-bonding, metal-to-metal bonding, 
agostic interactions, bent bonds and three-centre two-electron bonds (Huang et al., 
2012; Smith and March, 2007; Miessler and Tarr, 2004). 
A non-covalent interaction differs from a covalent bond in that it does not 
involve the sharing of electrons, but rather involves more dispersed variations of 
electromagnetic interactions between molecules or within a molecule (Anslyn, 
Dougherty, 2006). The chemical energy released in the formation of non-covalent 
interactions is typically on the order of 1-5 kcal/mol (1,000–5,000 calories per 6.02x 
10^23 molecules) (Lodish et al., 2000). Non-covalent interactions can be generally 
classified into four categories, electrostatic, π-effects, van der Waals forces and 
hydrophobic effects (Table 2.2. Chemical bonds). 
Table 2.2. Chemical bonds and interactions 
Intramolecular 
(“strong”) 
Covalent 
bond 
By symmetry Sigma (σ); Pi (π); Delta (δ); Phi (φ) 
By multiplicity 1 (single); 2 (double); 3 (triple); 4 (quadruple); 5 (quintuple); 6 
(sextuple) 
Miscellaneous Agostic bond; Bent bond;  Dipolar bond; Pi backbond;  
Charge-shift bond;  
Hapticity; Conjugation; 
Hyperconjugation;  
Antibonding.  
 Resonant 
bonding 
Electron-deficient (3c–2e 4c–2e); 
Hyper-Coordination 
(3c–4e); Aromaticity.  
Metallic bonding Metal aromaticity 
Ionic bonding Polar covalent bonds 
Intermolecular 
(“weak”)  
 
 
 
Van der Waals forces Force between two permanent dipoles (Keesom force) 
Force between a permanent dipole 
and a corresponding induced dipole 
(Debye force) 
Force between two instantaneously 
induced dipoles (London dispersion 
force). 
 Dispersion forces. 
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Intermolecular 
(“weak”) 
Hydrophobic effects The segregation and apparent repulsion between water and nonpolar 
substances  
Hydrogen bond Low-barrier; Resonance-assisted Symmetric; Dihydrogen bonds  
C–H···O interaction 
Electrostatic Stationary or slow-moving electric 
charges with no acceleration 
π-effects Metal-π Interactions (cation-π or 
neutral interactions); Polar-π 
interactions; Aromatic-aromatic 
interactions (π stacking); π donor-
acceptor interactions; Anion-π 
interactions; Cation-π interactions; C-
H-π interactions. 
 
Graphene or graphene oxide covalently attached usually occurs through 
oxygen linkages (oxygenated functional groups) (Liu, et al., 2008) or through 
structural π-π networks, non-covalently by π-π stacking (Table 2.3) (Lonkar, 
Deshmukh and Abdala, 2015; Zhang et al., 2010).  
 Table 2.3. Graphene functionalisation 
Covalent modification of graphene 
Covalent Attachment of Organic Functionalities to Pristine Graphene 
Free radical addition to the sp2 
carbon atoms of graphene 
Covalent 
modification of 
graphene oxide (GO) 
Functionalisation of 
partially reduced graphene 
Covalent modification of 
graphene using dienophiles 
a) Amidation  
b) Esterification 
c) Silanisation 
d) Other GO 
functionalisation’s 
Non-covalent modification of graphene 
Polynuclear 
aromatic rings 
Surfactants and 
ionic liquids 
Biomolecules and 
macromolecules 
Attachment of 
nanoparticles 
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Graphene/graphene oxide functionalisation with porphyrins chosen due to a 
very promising approach because of a fusion of unique properties of both 
counterparts can generate advanced nanocomposites for broad applications in 
nanomedicine and biotechnology. Depending on the chosen porphyrins the 
graphene/graphene oxide can be functionalised by using different types of 
modifications: covalent (amidation, esterification, radical addition to the sp2 carbon 
atoms and other functionalisation) and non-covalent (through Van der Waals forces, 
electrostatic, π interactions, hydrophobic effect, etc.) (Georgakilas, 2012).  
Subsequently, whereas it was revealed that graphene oxide nanoparticles have 
a higher toxicity for cancer cells than healthy ones, the GO functionalisation with 
doxorubicin, the drug used in cancer chemotherapy, was performed. The 
combination of GO and DOX may help reduce the concentration and the side-effects 
of each and increases the effectiveness of anticancer drug.  
2.2.3 Graphene oxide 
Graphene oxide is a two-dimensional carbon layer with oxygen-containing 
functional groups (epoxy, hydroxyl and carboxyl) on the basal plane and at the 
edges (Fig. 2.3). Those characteristics let graphene oxide change the shape, size and 
relative fraction of the sp2-hybridised domains and make it a very promising 
material for the biomedical system (Shen et al., 2012; Zhang et al., 2011; Zhang, 
Zhang and Xu, 2012).  
 
Fig. 2.3. Structure of graphene oxide molecule (Hamilton, 2009) 
One of the most popular methods to obtain graphene oxide is Hummers’ 
method (Offeman and Hummers, 1958). Briefly, the graphite powder is affected 
with a mixture of H3PO4 and concentrated H2SO4 acids, and then KMnO4 (Fig. 2.4). 
After completing the oxidation of graphite, the reaction mixture is quenched by 
H2O2. The colour of the mixture changes from dark brown to bright yellow, 
indicating the formation of GO.  
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Fig. 2.4. The synthesis of GO by Hummers’ method (Zuo et al., 2013) 
Other methods include the oxidation of graphene; various Hummers’ method 
modifications, for example, excluding the NaNO3, increasing the amount of KMnO4 
and performing the reaction in a 9:1 mixture of H2SO4/H3PO4 (this method provides 
a greater amount of hydrophilic oxidised graphene) (Marcano et al., 2010), the 
synthesis of GO by sonication-assisted oxidation of graphite in a solution of 
potassium permanganate and concentrated sulfuric acid followed by reduction with 
ascorbic acid (Abdolhosseinzadeh, Asgharzadeh and Kim, 2015); using a Tang-Lau 
synthesis method in which the sole source is glucose, this process is safer, simpler 
and more environmentally friendly. Another important advantage of the Tang-Lau 
method is the control of thickness, ranging from monolayer to multilayers by 
adjusting the growth parameters (Tang et al. 2012).  
The possible applications of GO are also very wide; laboratory reagent, 
catalyst, carrier, biological drug, filter medium, adsorbent, gas-barrier material, 
preservative, electrostatic shielding film, polymeric composite, transparent electrode 
material (Fig. 2.5). 
 
Fig. 2.5. Promising applications of graphene oxide (Yuta, 2013) 
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2.2.4 Biomedical applications of graphene/graphene oxide 
Beyond the wide possible applications of graphene in fields such as 
nanoelectronics (Xuan et al., 2008), composite materials (Yang et al., 2010; Fan et 
al., 2010; Bai et al., 2010; Sun, Wu, 2011; Fang et al., 2010), energy technology 
(Liu et al. 2010; Stoller et al., 2008; Wang et al. 2009), sensors (Lu et al. 2009) and 
catalysis (Qu et al., 2010), the biomedical application of graphene is a relative new 
area with significant potential. The first study on graphene for biomedical 
applications was the report on the use of graphene oxide as an efficient nanocarrier 
for drug delivery by Liu et al. in 2008 (Liu et al., 2008). Since then, a lot of 
interesting work has been carried out to explore the use of graphene and his 
derivatives for widespread biomedical applications, such as (Shen et al., 2012): 
• drug delivery, 
• gene delivery,  
• biological sensing,  
• biological imaging,  
• GO-based antibacterial materials, 
• GO-based biocompatible scaffold for cell culture.  
It was found that graphene and especially its oxidised modification, graphene 
oxide, can be highly optimised for their specific functions in vivo and possess 
features that are often desired in drug delivery carriers (Allen and Cullis, 2004). The 
first step to use graphene oxide as a drug delivery carrier is a functionalisation of 
GO with a functional molecule, particle, etc. In particular, GO was effectively 
functionalised with anticancer drugs like doxorubicin (Zhang, 2010; Yang et al., 
2008; Yang et al., 2011; Zhang et al., 2013). Porphyrins, as well, were successfully 
linked with GO via both p–p stacking and covalent bonding between amino and 
carboxyl groups (Ye et al., 2012; Liu et al., 2009). In particular, for a drug delivery 
system GO branched by polyethylene glycol represents a set of features like good 
solubility and stability in physiological solutions, also the unique ability of the 
graphene structure to attach and deliver aromatic, water insoluble drugs (Yang, Xu, 
2013). 
The most important examples of GO surface modifications are with precursors 
such as polyethylene glycol, folic acid, chitosan, polyethyleneimine, polyacrylic 
acid, amphiphilic copolymers, sulfonic acid and amino group, dextran, gelatine, 
nanoparticles, etc. (Feng, Liu, 2011). There is a rising interest for the GO-polymers 
drug carrier systems for transferring a water-insoluble anticancer drug like 
doxorubicin. Wenjun Miao and others reported the safety, tumour accumulation and 
potential of polyethylene glycol-grafted graphene oxide (pGO) as a multimodal 
nanocarrier of photosensitisers and synergistic anticancer agents such as 
Doxorubicin (Miao et al., 2013). Liang Yan and colleagues used a 
polyethyleneimine-modified graphene oxide as a nanocarrier of an aromatic drug; 
the active formulation did not exhibit toxicity on the human endothelial cells and 
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showed a high potency of killing cancer cells in vitro (Yan et al., 2013). In another 
study, a GO-based multifunctional hybrid functionalised by magnetic/fluorescent 
SiO2 microsphere via an amidation process has been developed for the loading and 
delivery of drugs. This application of the developed GO-based magnetic fluorescent 
hybrids for HepG2 cells demonstrated a good therapeutic effect (Gao et al., 2013).  
While drug delivery also involves membranes, attention should be paid to 
nanoparticle interactions with the membrane. The goal of an ideal drug delivery 
system is to deliver a drug to a specific site, in a specific time and release pattern. 
Also, there are many other requirements such drug permeability, good release 
properties, etc. (Simo, Cifuentes and Gallardo, 2003; Stamatialis et al. 2008). It was 
found that the lipid monolayer functionalised graphene nanomaterials exhibited 
excellent performance as a carrier for loading the anticancer drug, doxorubicin, with 
a high loading capacity of 70% and the loaded drug can be released under pH 
control (Liu et al., 2015). However, the interaction of GO nanoparticles with 
membranes is still inconclusive. In experimental conditions the membrane 
characteristics cause diverse uptake pathways of nanoparticles into cells, the cell 
response, etc. Therefore, more studies to understand the mechanism and possible 
response of different types of membranes/cells are needed.  
2.2.5 Graphene oxide functionalisation with porphyrins 
Porphyrins are heterocyclic macrocycles composed of four modified pyrrole 
subunits interconnected at their α-carbon atoms via methine bridges (=CH−). 
Porphyrin macrocycles are highly conjugated planar systems, and, correspondingly, 
demonstrate a high-level of both light absorption and emission, which can be 
efficiently modulated by peripheral substitutes. Many porphyrins are naturally 
occurring; one of the best-known porphyrins is heme (iron-containing porphyrin), a 
cofactor of the protein haemoglobin. Heme-containing proteins (haemoproteins) are 
found extensively in nature. Myoglobin and haemoglobin are two O2-binding 
proteins that contain iron porphyrins.  
Porphyrins are the conjugate acids of ligands that bind metals to form 
complexes. The metal ion usually has a charge of 2+ or 3+. A porphyrin without a 
metal-ion in its cavity is a free base (Fig. 2.6).  
A schematic equation for these syntheses is shown:  
H2 porphyrin + [MLn]2+ → M (porphyrinate) Ln−4 + 4 L + 2 H+ (2.1) 
where: M = metal ion, L = a ligand 
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Fig. 2.6. The structure of porphyrins (Ikawa, 2008) 
In non-photosynthetic eukaryotes, the committed step for porphyrin 
biosynthesis is the formation of δ-aminolevulinic acid by the reaction of the amino 
acid glycine with succinyl-CoA from the citric acid cycle. In plants, it is produced 
from glutamic acid via glutamyl-tRNA and glutamate-1-semialdehyde (also known 
as C5 or the Beale pathway).  
One of the most common laboratory syntheses for porphyrins is based on work 
by Rothemund (Rothemund, 1935; Rothemund, 1936). This synthesis is a 
condensation and oxidation starting with an aldehyde and pyrrole (Fig. 2.7). 
 
Fig. 2.7. The porphyrin synthesis by Rothemund method (Rothemund, 1935) 
Other techniques described by Adler et al. (1967) and Falvo et al. (1999) are 
more modern and are used commonly in university teaching labs. The disadvantage 
of these methods, that in solution-phase synthesis, acidic conditions are essential. 
Indeed, there are also green chemistry variants (no additional acids are required) 
performed with microwave irradiation using reactants adsorbed on acidic silica gel 
(Pettit et al. 1992) or at a high temperature in the gas phase (Drain et al., 1997).  
It was precisely those optical properties of porphyrins that stimulated the use 
of porphyrin as photosensitisers (PHS) in Photo Dynamic Therapy (PDT) and 
Fluorescence Diagnosis (FD) (Dong et al., 2010). Both PDT and FD are based on 
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the administration of photosensitisers that preferentially accumulate in cancerous 
tissues, followed by exposure of the tumour area to visible light of the proper 
wavelength, and results in an energised form which, upon decay, results in 
cytotoxicity. Excited photosensitiser molecules are then deactivated through two 
main processes: emission of fluorescence from the lowest excited singlet state of the 
photosensitiser (principle of FD) or generation of reactive oxygen species via the 
lowest triplet state of the photosensitiser (principle of PDT). Many PHS used 
clinically in PDT such as Photofrin®, Visudine® and Foscan® are based on the 
porphyrin structure (Banfi et al., 2012). 
However, porphyrins are usually unstable during light exposure and their 
photo-degradation is mediated by singlet oxygen (Inhoffen et al., 1969; Krieg and 
Whitten, 1984; Moan and Kessel, 1988; Rotomskis, Streckyte and Bagdonas, 1997). 
Recent studies show that the use of nanocarriers significantly improve the photo-
physical properties of porphyrins in respect of their free form in aqueous solutions, 
porphyrin based PHS encapsulated in various nanocarriers (liposomes, micelles, 
nanoparticles) demonstrate stronger absorption, and a high-level of singlet oxygen 
generation without damage from PHS, etc. (Xie et al., 2014). However, up to now 
the available information on the effect of GO on the optical properties of porphyrins 
is quite limited, in particular on ones of natural origin like hematoporphyrin (HP), an 
endogenous porphyrin formed by the acid hydrolysis of haemoglobin (Luzgina et 
al., 1977) that has been used as an antidepressant and antipsychotic as well as in 
phototherapy of cancer since the 1920s (Strecker, Palmer and Braceland, 1934; 
Rassmussen-Taxdal and Ward, 1955; Dolmans, Fukumura and Jain, 2003). At the 
same time, HP~GO aggregate can also be used in new drugs for PDT/FD if HP~GO 
based formulations demonstrate high luminescence intensity and increased 
protection against singlet oxygen damage. The present study is directly within this 
concept. 
The optical properties of hematoporphyrin strongly depend on its aggregation 
state, position of the bands, their intensity and luminescence efficiency, and singlet 
oxygen production rate drastically decreased under the aggregation of HP 
(Kotkowiak, Łukasiewicz and Dudkowiak, 2013). The main approach to increase the 
efficiency of HP as a PDP/FD specific drug is to prevent the formation of aggregates 
using i) oligomerisation, (ii) changing the equilibrium to the monomeric forms 
(encapsulation) or (iii) by inducing formation of monomer friendly organised 
architectures. The first approach i) was successfully realised by S. Schwartz in 1960 
for the detection of tumours by treating hematoporphyrin with concentrated sulfuric 
acid (Schwartz, Absolon and Vermund, 1955; Lipson, Baldes and Olsen, 1961). The 
more effective bioactive products of this reaction are porphyrin oligomers 
containing 2 to 8 pyrrole rings connected by ester bonds. The possibility of the 
oligomerisation process is the result of the structural features of hematoporphyrin. 
Indeed, HP is an iron-free derivative of heme with 4 methyl groups, 2 hydroxyethyl 
groups (secondary alcohols) and 2 propionic acid (carboxylic) groups attached to the 
pyrrole rings. As dihydroxy and dicarboxylic acid, derivative HP can be involved in 
the Fischer/Fischer–Speier esterification reaction in the presence of an acid catalyst. 
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Sulphuric acid in this case is a catalyst in esterification reactions, which has been 
well known for many years (Marchetti, Errazu, 2008; Deng et al., 2001). 
The actual challenge is to extend the use of the “oligomerisation approach” in 
new hematoporphyrin through its combination with nanostructured carriers. In line 
with that, the main focus of the activity within this area is on developing a less-
costly and more efficient approach to enhance the photodynamic efficiency of HP 
through the self-assembling of GO and hematoporphyrin in functional architectures. 
2.2.6 Graphene oxide functionalisation with doxorubicin 
Doxorubicin (also known as Adriamycin) is a drug used in cancer 
chemotherapy. Doxorubicin is a glycoside antibiotic, it consists of the tetracyclic 
quinoid aglycone adriamycinone (14-hydroxydaunomycinone) linked to the amino- 
sugar daunosamine (Fig. 2.8).  
 
Fig. 2.8. Structure of doxorubicin (Tacar, Sriamornsak and Dass, 2013) 
It is derived by aerobic fermentation from a bacterial species, Streptomyces 
peucetius var. caesius, or by chemical synthesis from Daunomycin. It is an 
anthracycline antitumor medicine and works by intercalating DNA and inhibition of 
macromolecular biosynthesis (Tacar, Riamornsak and Dass, 2013). It is commonly 
used in the treatment of a wide range of cancers and is often used in combination 
chemotherapy as a component of various chemotherapy treatments. 
The adverse effects of doxorubicin include hair loss, suppression of the body’s 
bone marrow to produce new blood cells, nausea and vomiting, skin reactions and 
many others (Rossi, 2013). Although the most dangerous side-effect of doxorubicin 
is cardiomyopathy, leading to congestive heart failure. The rate of cardiomyopathy 
is dependent on its cumulative dose. The incidence of cardiomyopathy is about 4% 
when the dose of doxorubicin is 500-550 mg/m² and 36% when the dose exceeds 
600 mg/m² (Chatterjee et al., 2010). Doxorubicin is available as the hydrochloride 
salt (Andriamycin), in liposome-encapsulated forms as Doxil (pegylated form), 
Myocet (nonpegylated form) and Caelyx, all these forms must be given by 
intravenous injection (Brayfield et al., 2014). 
Recently, many studies of the combination of GO with doxorubicin have been 
performed due to the possible synergetic effect of these materials. It was reported 
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that Graphene oxide has an anticancer action and can be used as a pH-sensitive 
drug-carrier for other drugs (Cheng et al., 2015; Zhou, Zhou and Xing, 2014). 
Meanwhile, the adverse effects of doxorubicin could be reduced, because lower 
doses could be used. One of the main benefits of using a GO hybrid is the controlled 
release of loaded material (Balcioglu, Rana and Yigit, 2013; Ardeshirzadeh et al., 
2015). In the near future these hybrids could serve as a promising platform for 
theranostics due to the anticancer drug loading capacity and the possibility to add a 
contrast agent. 
2.3 Lipid membranes 
All living cells are surrounded by a membrane that physically separates the 
interior components of the cell from its environment. It acts as a protective barrier 
that is selectively-permeable to ions and certain organic molecules, controlling the 
movement of substances in and out of the cell. Cell membranes consist of numerous 
biological molecules that are involved in a variety of cellular processes such as cell 
adhesion, ion conductivity and cell signalling. These molecules diffuse more or less 
freely in a high fluidity system, known as the liquid mosaic model (Singer and 
Nicolson, 1972). 
The main structure of a cell membrane is made up of proteins that are partially 
embedded in a bilayer of phospholipids. Phospholipids are a type of lipid molecule. 
Lipids are organic compounds that consist of a ‘tail’ of long fatty acid hydrocarbon 
chains and a carboxyl ‘head’. In the case of phospholipids, the ‘head’ contains a 
negatively-charged phosphate group making it highly polar and hydrophilic (Fig. 
2.9). Conversely, the ‘tail’ is very hydrophobic. Therefore, when placed in water, 
phospholipids spontaneously arrange to point their ‘tails’ inwards towards each 
other and their ‘heads’ outwards towards the water, forming a membrane. In cellular 
membranes, this takes the shape of a bilayer; however, lipids can group together to 
form a variety of structures depending on their concentration, chemical structure and 
experimental conditions: 
• Monolayer – a single layer film of lipids at an air-water interface 
formed by compression in a Langmuir-Blodgett trough; 
• Micelle – a colloid of lipids in an aqueous suspension that is 
hydrophilic on the outside and hydrophobic on the inside; 
• Bilayer – the natural, energetically-favoured form that lipids take in 
an aqueous environment; 
• Liposome, or vesicle – the spherical form of a bilayer with an 
aqueous core. 
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Fig. 2.9. Structure of phospholipid molecule (modified by Pogodin, Baulin, 2010) 
Forces such as van der Waals and electrostatics, hydrogen bonds and non-
covalent interactions contribute to the formation of a lipid bilayer. However, 
hydrophobic interactions are the major driving force in this process.  
Depending on the absence or presence respectively of a carbon-carbon double 
bond within their ‘tail’, phospholipids can be saturated or unsaturated. The 
difference in saturation can cause variations in the thermodynamic properties of 
lipids that are otherwise structurally and chemically identical; unsaturated 
phospholipids tend to have a much lower phase transition temperature than saturated 
phospholipids. This is due to the disorder that arises from the presence of a carbon-
carbon double bond in the molecule; the repulsion of electrons within the bond 
causes the hydrogen atoms to move outwards and produces a kink in the lipid ‘tail’. 
The level of this disorder, and consequently the temperature at which an unsaturated 
phospholipid changes phase, depends on the number and position of these carbon-
carbon double bonds (Koynova and Caffrey, 1998). This property is significant 
when saturated and unsaturated phospholipids are combined in a bilayer structure. 
The phospholipids, at a wide range of temperatures, are in different phases that 
separate out across the membrane and then cluster together to form regions known 
as microdomains. Microdomains are regions of tightly-packed saturated lipids in an 
ordered gel state that protrude from the fluidity of the loose unsaturated “kinked” 
lipids in a disordered liquid crystalline state. The regions vary in size and height 
depending on the type and concentration of the lipids and the ambient temperature of 
the membrane (Elliott et al., 2005).  
2.3.1 Bilayer lipid membrane synthesis 
There are two main lipid membrane synthesis methods: 
• Lipid vesicle fusion 
• Langmuir-Blodgett technique 
By the lipid vesicle fusion method, thin lipid films are hydrated to form stacks 
of liquid crystalline bilayers that become fluid and swell. These bilayers detach 
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through agitation and self-close to form large, multilamellar vesicles that are 
reduced in size and fused to a solid support.  
The Langmuir-Blodgett technique is a slightly less common way to produce 
lipid membranes. This method uses a rectangular Teflon bath equipped with 
moveable barriers that compress a monolayer of amphiphilic molecules on an air-
water interface and transfer it onto a solid support (see Fig. 2.10). 
 
Fig. 2.10. Scheme of methods used for preparing BLMs for atomic force microscopy 
analysis: (a) Langmuir–Blodgett technique and (b) fusion of lipid vesicles (Mingeot- 
Leclercq et al. 2008) 
Very important parameters for supporting the lipid membranes are the contact 
angle and wetting properties of the surface. Wettability studies usually involve the 
measurement of contact angles, which indicates the degree of wetting when a solid 
and liquid interact. Small contact angles correspond to high wettability, while large 
contact angles correspond to low wettability (Fig. 2.11). The equilibrium contact 
angle is given by Young’s equation,  
γLV Cosθe = γSV – γSL (2.2) 
where γSL, γSV and γLV are solid-liquid, solid-vapour and liquid-vapour 
interfacial tensions which measure the free energy (per unit area), θe is the 
equilibrium contact angle (Adamson, et al. 1997). 
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Fig. 2.11. Liquid drop on a solid surface. The condition θ < 90° indicates that the solid is wet 
by the liquid, and θ > 90° indicates non-wetting, with the limits θ = 0 and θ = 180°defining 
complete wetting and complete non-wetting, respectively (Derrick et al., 2007) 
The fusion of vesicles at a surface to form a supported bilayer can occur only 
on surfaces that are sufficiently hydrophilic, the static contact angle should be < 10 
degrees. On the other hand, vesicles that settle on the surface tend to remain 
vesicular. When vesicles adsorb to strongly hydrophilic surfaces, they spread to 
maximise contact with the surface while causing increasing surface tension on the 
vesicle wall, and eventually rupture to form the supported bilayer. The other way is 
to form lipid monolayers by using ligands, mostly alkanethiols, which can be easily 
tailored (e.g., using different terminal groups and chain lengths) to change the 
hydrophobicity. Using hydrophobic self-assembled monolayers (SAM), due to the 
interaction between the hydrophobic chains with the modified substrate, a lipid 
monolayer can be formed (Fig. 2.12).  
 
Fig. 2.12. Bilayer membrane formation on: a) hydrophilic surfaces. b) alkyl-SAM terminated 
surfaces (Tero, Watanebe and Urisu, 2006) 
2.3.2 The analysis methods of lipid membranes 
The bilayer lipid membranes (LM) are increasingly accepted as experimental 
models commonly employed for both fundamental and applied studies 
(Sweetenham, 2010; Vemula and Fedorova, 2015). The most common methods used 
to characterise LMs are fluorescence-based techniques, such as confocal 
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microscopy, fluorescence correlation spectroscopy (FCS), Förster resonance energy 
transfer (FRET), total internal reflection fluorescence (TIRF) or two-photon 
microscopy (Sezgin, and Schwille, 2011). However, some of these methods require 
labelling, they also provide limited data about the structure of LMs. Vibrational 
spectroscopies, such as infrared (IR) or Raman are eligible analytical tools for the 
investigations of LMs because of their ability to provide information about the 
structure of the LM as well as its chemical composition (Baeten, 2010; Lewis and 
McElhaney, 2013). Indeed, IR analysis of the samples prepared in aqueous medium 
is complicated due to the strong and temperature dependent absorption of water, 
while Raman spectroscopy allows this problem to be avoided. This aspect is 
important with regard to biological samples, including lipid membranes, requiring 
the maintaining of native conditions. However, the analysis of lipid membranes by 
Raman spectroscopy is complicated due to its low sensitivity and spatial resolution 
(Sweetenham and Notingher, 2010). This problem can be facilitated by the usage of 
Surface enhanced Raman scattering (SERS) spectroscopy enabling the enhancement 
of the Raman signal of lipid membranes. In recent years, a number of reports have 
been published showing the successful application of SERS for the investigation of 
lipid-protein interactions (Petersen and Nielsen, 2009; Suga et al., 2015; Kühler, 
Weber and Lohmüller, 2014; Kundu, Levin and Halas, 2009; Ren et al., 2011; Li et 
al., 2014). It has been shown that in cases when gold nanoparticles (NP) are used, 
the formation of LM is complicated. The modification of SERS substrates should be 
done because Au NPs are hydrophilic and immiscible in organic solvents or lipid 
systems (McClements, 2014), and the contact angles of the surface are often 
inappropriate to form the lipid membrane. In order, to create a lipid monolayer 
around Au NPs, they must be modified with ligands, mostly alkanethiols, to increase 
the hydrophobicity and the dispersibility of Au NP within the lipid phases. The other 
way is to use thiol-modified lipids for the formation of bilayer LM on gold 
nanoparticles (Castellana, Gamez and Russell, 2011) or to modify gold nanoparticle 
surfaces with halide ions (Kah et al., 2012; Orendorff et al., 2009). 
 It is known that the ability to form a bilayer on the surface can be explained 
by differences in the hydrophilicity of the two substrates (Cha, Guo and Zhu, 2006). 
The fusion of vesicles at a surface to form a supported bilayer can occur only on 
surfaces that are sufficiently hydrophilic. On the other hand, vesicles that settle on 
the surface tend to remain vesicular. When vesicles adsorb to strongly hydrophilic 
surfaces, they spread to maximise contact with the surface while causing increasing 
surface tension on the vesicle wall, and eventually rupture to form the supported 
bilayer. The ability of adsorbed vesicles to spread on a surface can be estimated by 
the static contact angle made by a droplet of water on the surface, it should be < 10 
degrees. The other way is to form lipid monolayers by using ligands, mostly 
alkanethiols, which can be easily tailored (e.g., using different terminal groups and 
chain lengths) to increase the hydrophobicity. Using a hydrophobic SAM, due to the 
interaction between the hydrophobic chains with the modified substrate, a 
monolayer is obtained (Marques, De Almeida and Viana, 2014). 
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2.3.3 Lipid membrane interaction with nanoparticles 
Lipid membranes are essential components of any living cell and lipid 
membranes are simplified planar models of cell membranes, commonly employed 
for fundamental and applied studies. LM as a model system are of great importance 
for improving our understanding of cell interaction with the environment, various 
disease mechanism and membrane properties for drug screening purposes. An 
important area of nanomedicine research is the interaction of nanoparticles with cell 
and possible toxicity (Heikkila et al., 2014; He et al., 2015; Karlsson et al., 2013; 
Adjei, Sharma and Labhasetwar, 2014; Lu et al., 2014). Apart from LMs mechanical 
function as a cell wall, the lipid membrane performs the function of a transfer 
mechanism for molecules diffusing through the membrane. As this process could 
distort the membrane structure, characterisation tools are needed that enable us to 
study the structure and ordering of the membrane. The influence of NPs on the 
membrane materials are known to be more environmentally and biologically 
friendly than inorganic materials and it is one of the most common elements in our 
ecosystem. Especially, graphite is a naturally occurring material and it can be 
expected that graphene, a single layer of graphite, will be safe and useful for 
biological purposes. Carbon nanotubes and graphene oxide have attracted attention 
as promising carbon nanomaterials in different applications (Chabot et al., 2014; 
Hakimi and Alimard, 2012; Dreyer, Todd and Bielawski, 2014). In biomedical 
applications and nanomedicine, GO have been utilised over existing drug delivery 
vectors due to their ability to cross cell membranes easily and their high surface 
area, which provides multiple attachment sites for drug targeting (Chung, Won and 
Zelenay, 2013; Krishna et al., 2013). 
2.3.3.1 Lipid membrane interaction with graphene/graphene oxide 
Cell interaction with graphene microsheets can either undergo a near-
orthogonal cutting or a parallel attachment mode with cell membranes. Recently, the 
theoretical analysis to characterise the deformed membrane microstructure and 
investigate how these two interaction modes are influenced by the splay, tilt, 
compression, tension, bending and adhesion energies of the membrane was 
performed by Yi and Gao (2015). This analysis indicates that, driven by the 
membrane splay and tension energies, a two-dimensional microsheet such as 
graphene would adopt a near-perpendicular configuration in the transmembrane 
penetration mode; the membrane bending and tension energies would lead to parallel 
attachment in the absence of cross membrane penetration (Fig. 2.13).  
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Fig. 2.13. Modes of interaction between cell membranes and graphene microsheets: a) Near-
perpendicular penetration of graphene microsheets into the membrane b) Parallel attachment 
and spreading of graphene microsheets onto the membrane (Yi and Gao, 2015) 
These interaction modes may have broad bio-medical implications in 
applications. The membrane penetration by 2D nanomaterials, such as a graphene 
oxide (GO); reduced graphene oxide (rGO) and other related material microsheet, 
whose surfaces are hydrophobic or can exhibit other specific adhesive interactions 
with the lipid tails. In this case, the length scale of the concerned local membrane 
deformation is comparable with the bilayer thickness and the elastic energy of a 
monolayer. The elastic energy principally results from the deformation of the 
hydrocarbon chains (Lipowsky and Sachmann, 1995). Another important mode of 
the interaction is the parallel attachment of micro-sized 2D nanomaterials on cell 
membranes. For the transmembrane-penetration mode, the membrane thickness and 
scales of local membrane deformation are comparable, and the penetration is driven 
by the (hydrophobic) attraction between lipid tails (interior of the bilayer) and 
nanomaterial surface. Conversely, the parallel attachment mode is mostly facilitated 
by the hydrophilic or highly specific attraction between the bilayer surface and 
nanomaterial surface. Consequently, the cell membrane can be simply modelled as a 
smooth and structureless surface with consideration of the bending and tension 
energies.  
It was noticed that bending and membrane tension energies serve as the main 
driving force for the parallel configuration of transmembrane (membrane attaching) 
2D nanomaterials. On the other hand, the orientation of one-dimensional 
nanomaterials wrapped by a cell membrane is tension-dependent, the nanomaterials 
displaying a parallel configuration at a small (large) tension (Yi, Shi and Gao, 2014). 
The orientations of inserted molecules in a lipid bilayer and one-dimensional 
transmembrane nanomaterials have implied a near-perpendicular transmembrane 
configuration.  
The interactions between graphene nanosheets and cell membrane show 
different effects. The pristine graphene can readily penetrate into the bilayer and has 
no effect on the integrity of membrane (Fig. 2.14). 
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Fig. 2.14. The trajectories of pristine graphene located vertically a) or lay flat b) in the centre 
of the membrane with snapshots at each tilt angle (Modified by Chen et al., 2016) 
Pristine graphene can easily penetrate into the membrane and could only 
remain vertical with slight fluctuations. The fast insertion of pristine graphene into 
the lipid bilayer is driven by the hydrophobic and strong dispersion interactions 
between graphene and lipids. The interaction of bigger graphene sheets with the 
bilayer can slightly deform the membrane without any significant damage. 
On the other hand, when GO is embedded in the membrane, several lipids are 
pulled out of the membrane to the surface of the GO, resulting in the pore formation, 
and water molecules flowing into the membrane. The difference between pristine 
graphene and graphene oxide in the membrane originates from GO’s oxygen-
contained groups, which enhance the adsorption of the lipids on the GO surface. 
Indeed, the main interactions between GO and the membrane are determined by the 
strong dispersion interactions between its hydrophobic domains and the lipid tails of 
the bilayer (Chen et al., 2016).  
 
Fig. 2.15. The trajectories of graphene oxide when: a)-d) GO lay flat initially at the 
membrane centre; e)-h) GO was positioned vertically at the membrane centre. b), f) are the 
final configurations of simulations. c), g) are the side views of water distributions. d), h) are 
the top views of bilayers, where black circles specify the water pores. (Modified by Chen et 
al., 2016) 
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Different from the graphene fast insertion, GO remain at the interface between 
the head groups and water. The difficulty for GO to enter the membrane is due to the 
fact that oxygen contained groups render GO much more hydrophilic (Chen et al., 
2016). Though, GO can still enter the membrane by cell’s endocytosis due to its 
nanosize.  
2.4 Impact of nanoparticles on cells viability 
Human lungs, skin and the gastro-intestinal tract are in constant contact with 
the environment. These three ways are the most likely points of entry for 
nanoparticles. Injections and implants are possible routes of exposure to engineered 
nanomaterials. Nanoparticles, due their small size, can translocate from these entry 
portals into the circulatory and lymphatic systems, body tissues and organs. Some 
nanoparticles can produce irreversible damage to cells by oxidative stress and 
organelle injury. It is important to understand why and how nanoparticles are able to 
enter cells and interact with various cells and their components like nucleus, 
mitochondria, etc. (Buzea, Pacheco and Robbie, 2007). Nanoparticle toxicity 
depends on chemical composition, shape, particle ageing, uniformity, size and 
agglomeration state (see Fig. 2.16). It was shown that the surface charge and 
aggregation state of nanomaterials critically influence their in vitro cytotoxicity. The 
surface charge of nanoparticles plays an especially important role in cell-
nanoparticle interactions because cell membranes themselves are charged. It is also 
very important to understand that nanoparticles can be toxic, non-toxic, or even 
appear to have beneficial health effects. Examples of positive effects are that 
nanoparticles could be used as antioxidants, fullerene derivatives (Bosi et al., 2003), 
and nanoparticles made of compounds holding oxygen vacancies (Cerium oxide and 
Yttrium oxide) (Schubert et al., 2006) have demonstrated neuroprotective properties 
and antiapoptotic activity, and as anti-microbial agents several types of nanoparticle 
(silver (Prabhu and Poulose, 2012), titanium dioxide (Jesline et al., 2015), fullerenes 
(Tegos et al., 2005), zinc oxide (Tayel et al., 2011) and magnesium oxide (Tang and 
Lv, 2014) have an antimicrobial effect. 
39 
 
 
 
Fig. 2.16. Classification of nanomaterials from the point of view of nanostructure 
dimensions, morphology, composition, uniformity and agglomeration state (Buzea et al., 
2007) 
2.4.1 Nanoparticle and protein corona 
The surface of nanomaterials is covered by protein corona upon their entrance 
to the biological medium. The biological medium modifies the surface of 
nanomaterials, and therefore further cellular responses depend on the composition of 
the corona. The corona variations could be according to the physicochemical 
properties of the nanomaterials (e.g., size, shape, surface charge, surface functional 
groups, and hydrophilicity/hydrophobicity). The protein corona gives a new 
biological identity which is what is seen by cells. The biological identity determines 
the physiological response including agglomeration, cellular uptake, circulation 
lifetime, signalling, kinetics, transport, accumulation and toxicity (Rahman et al., 
2013).  
There are two types of protein corona: “hard” and “soft”. Proteins that adsorb 
with a high affinity form are known as “hard” corona, consisting of tightly bound 
proteins that do not readily desorb. Proteins that adsorb with low affinity form the 
“soft” corona, consisting of loosely bound proteins. 
Blood plasma contains around 1,000 different proteins with 12 order of 
magnitude differences in the concentration of these proteins (Monopoli et al., 2011) 
and lipids. Therefore, upon injection of nanoparticles into the blood, there is a 
competition between different biological molecules to adsorb on the surface of the 
nanoparticles (Fig. 2.17). In the initial stage, the most abundant proteins are 
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adsorbed on the surface; however, over time they will be replaced by higher affinity 
proteins (Vroman’s effect) (Vroman et al., 1980). 
The thickness of protein corona can vary due to many parameters such as 
protein particle size, concentration and surface properties of particles. Most plasma 
proteins present a diameter of 3–15 nm. A model for the protein corona has been 
proposed by Simberg et al (Simberg et al., 2009); it consists of “primary binders” 
that recognise the nanomaterial surface directly and “secondary binders” that 
associate with the primary binders via protein-protein interactions. Such a multi-
layered structure is significant for the physiological response as the secondary 
binders may alter the activity of the primary binders or “mask” them, preventing 
their interaction with the surrounding environment. 
 
Fig. 2.17. The scheme of protein corona formation. Proteins (blue-green) enclose a 
nanoparticle (green) that can bind to the cell membrane, e.g. to receptors (blue), like the free 
protein. (Rocker et al., 2009)  
The protein corona potentially transforms the biological identity of the particle 
and adds an additional level of complexity for the bio–nano responses. In the last 
year, studies have investigated the impact of the protein corona on nanoparticles 
such as amorphous silica nanoparticles (Docter et al., 2014; Lesniak et al., 2012), 
graphene oxide, iron-platinum and cadmiun selenide/zinc sulphide nanoparticles 
(Rocker et al., 2009), iron (Jansch et al., 2012), gold (Dobrovolskaia et al., 2009), 
silver (Shannahan et al., 2014), bare cadmium sulphide nanoparticles (Lynch, 
Dawson, 2008), polystyrene and carboxyl-modified polystyrene particles (Lundqvist 
et al., 2008). In general, the protein corona significantly affects cell vitality; 
automated high-throughput microscopy revealed that cell death was almost 
completely prevented upon treatment in the presence of serum or human plasma 
proteins. 
Recent studies have shown that protein BSA coating can mitigate the 
cytotoxicity of graphene oxide by reducing its cell membrane penetration. Protein 
corona decreases cellular uptake of GO. The adsorbed BSA weakened the 
interaction between the phospholipids and graphene surface due to a reduction of the 
available surface area significantly reducing the lipid bilayer damage (Duan et al., 
2015, Fig. 2.18).  
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Fig. 2.18. The scheme of how the protein corona formed in serum medium affects GO 
nanoparticles biological response (Duan et al., 2015) 
2.4.2 Impact of graphene on cells viability 
The most widely used nanomaterials are silver, carbon-based nanomaterials, 
silicon/silica, gold, zinc, titanium and iron. Carbon-based nanomaterials included, 
but are not limited to carbon nanotubes, fullerenes and graphene. In the last few 
years a lot of research studies were performed to determine the potential short and 
long-term toxicity of this new nanomaterial - graphene. A number of groups have 
devoted time and effort to explore the in vitro cytotoxic effects of graphene. It was 
reported that graphene prepared by the chemical vapour deposition technique 
increased the activation of caspase 3 (apoptosis marker), release of lactate 
dehydrogenase and generation of reactive oxygen species (ROS), in neural 
pheochromocytoma-derived PC12 cells (Zhang et al., 2010). Also, it was 
demonstrated that GO would induce significant cytotoxicity of human fibroblast 
cells at a GO concentration above 50 mg/l (Wang et al., 2011). Other scientific 
group uncovered that as-prepared GO only slightly decreased A549 cells 
proliferation rates without inducing apoptosis or cell death at an exposure 
concentration up to 85 mg/l. By contrast, reduced GO (rGO) after treatment by 
hydrazine hydrate exhibited a remarkable cytotoxicity to the same cell line (Hu et 
al., 2010). Though, GO after the biocompatible coating (for example, PEGylation) 
exhibited negligible in vitro toxicity to many cell lines (Raji, HCT-116, U87MG, 
MDA-MB-435, OVCAR-3, MCF-7) even at high concentrations up to 100 mg/l (Liu 
et al., 2008; Sun et al., 2008). 
The impact of carbon nanotubes and graphene on immune cells is still at a 
very early stage of investigation (Oreccioni et al., 2014). The authors suggest that 
GO does not enter the A549 cell and has no obvious cytotoxicity (Chang et al., 
2011). Indeed, GO can cause a dose-dependent oxidative stress in the cell and 
induce a slight loss of cell viability at high concentration. These effects are dose and 
size related, and should be considered in the development of bio-applications of GO. 
In conclusion, GO is a relatively safe material at a cellular level, which is confirmed 
by the favourable cell growth on GO film. The in vivo bio-distribution of graphene 
is also highly dependent on its surface chemistry. Also, how the size of nano and 
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different types of cell lines affects the in vivo behaviour of graphene requires further 
investigation. A lot more systematic exploration is demanded in order to fully 
understand the in vivo long-term fate and toxicology of graphene at different doses 
in various animal models before any clinical application of this novel nanomaterial 
(Feng, Liu, 2011). 
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3 MATERIALS AND RESEARCH METHODOLOGY 
3.1 Materials 
All reagents used in the experiments were chemically or analytically pure 
commercial reagents (see Table 3.1). 
Table 3.1. List of reagents used  
Reagent Manufacturer Formula 
Graphene oxide. Highly concentrated 
graphene oxide dispersion in water; 
500 mg/l. 
Graphene Supermarket, 
USA  
CxOyHz 
The high-quality CVD graphene films 
with coverage of about 95% of Si/SiO 2 
substrates  
Graphene Laboratories 
Inc., USA 
Cx 
Meso-tetra (4-sulfonatophenyl) 
porphine dihydrochloride (TPPS4) 
Mass: 1007.92; purity: >95% 
Frontier Scientific Inc., 
USA  
C44H32N4O12S4Cl2 
Fe(III) meso-tetra (4-sulfonatophenyl) 
porphine chloride (FeTPPS4)                                 
Mass: 1024.27; purity: >95% 
Frontier Scientific Inc., 
USA 
C44H28FeN4O12S4
Cl 
Hematoporphyrin IX dihydrochloride 
(HP). Mass: 671.61; purity: >95% 
Frontier Scientific Inc.  C34H40Cl2N4O6 
Meso-tetra (4-pyridyl) porphine (TPyP)                                        
Mass: 618.70; purity: >97% 
Frontier Scientific Inc., 
USA 
C40H26N8 
Doxorubicin hydrochloride (DOX), 
98.0-102.0% 
Sigma Aldrich, Germany C27H29NO11 · HCl 
Hydrochloric acid, 36.5-38.0% Sigma Aldrich, Germany HCl 
Sodium hydroxide, ≥97.0% Sigma Aldrich, Germany NaOH 
Deionised water. Refractive index-
n20/D 1.34(lit.); conductivity- ≤4.3 
μS/cm; density- 1.000 g/ml at 3.98°C. 
Sigma Aldrich, Germany H2O 
Sulfuric acid, 95-98% Carl Roth, Germany H2SO4 
Phosphate buffered saline (PBS), 
powder, pH 7.4 
Sigma Aldrich, Germany  9.0% NaCl; pH 
6.8±0.1 (25°C) 
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Reagent Manufacturer Formula 
Tris(hydroxymethyl)aminomethane 
(Tris), ≥99.8% 
Sigma Aldrich, Germany NH2C(CH2OH)3  
Ethylenediaminetetraacetic acid 
(EDTA), ≥98.0% 
Sigma Aldrich, Germany (HO2CCH2)2NCH
2 
CH2N(CH2CO2H)
2 
Sodium chloride, ≥99.0% Sigma Aldrich, Germany NaCl 
Calcium chloride, ≥99.9%  Sigma Aldrich, Germany CaCl2 
Calcium carbonate, ≥99.0% Sigma Aldrich, Germany CaCO3 
Sodium azide, ≥99.5% Sigma Aldrich, Germany NaN3 
2-propanol, 99.5% Sigma Aldrich, Germany (CH3)2CHOH 
1,2-dioleoyl-sn-glycero-3-phospho-L-
serine (DOPS), ~95% 
Sigma Aldrich, Germany C9H11NO5 
1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), ≥99% 
Sigma Aldrich, Germany C44H84NO8P  
1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE), ATTO 
647 labelled DOPE  
ATTO-TECH, USA C41H78NO8P 
Hydrofluoric acid, 48% Sigma Aldrich, Germany HF 
Ethanol, 96% Sigma Aldrich, Germany C2H5OH 
Silver nitrate, ≥99.0% Sigma Aldrich, Germany AgNO3 
Hydrogen tetrachloroaurate (III), 
≥99.9% 
Sigma Aldrich, Germany HAuCl4 · 3H2O 
Zinc oxide nanopowder, ~20 nm Nanogate AG, Germany ZnO 
Titanium dioxide nanopowder, ~35 nm NaBond, China TiO2 
Dulbecco`s modified Eagle medium 
(DMEM). Contain 1000 mg/l of 
glucose, L-glutamine, phenol red, 
sodium pyruvate and sodium 
Sigma Aldrich, Germany  
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Reagent Manufacturer Formula 
bicarbonate, powder, suitable for cell 
culture 
Foetal bovine serum (FBS), sterile-
filtered, haemoglobin, ≤20 mg/dl, 
impurities ≤10 EU/ml endotoxin, 
suitable for cell culture 
Sigma-Aldrich, Germany  
L-glutamine solution, sterile-filtered, 
concentration 200 mM, suitable for cell 
culture 
Sigma-Aldrich, Germany H2NCOCH2CH2C
H(NH2)CO2H 
Penicillin-streptomycin, solution 
stabilised, with 10,000 units penicillin 
and 10 mg streptomycin/ml, sterile-
filtered, suitable for cell culture 
Sigma-Aldrich, Germany  
Trypsin-EDTA solution, 0.25%, 
sterile-filtered, suitable for cell culture, 
2.5 g porcine trypsin and 0.2 g EDTA • 
4Na per litre of Hanks’ Balanced Salt 
Solution with phenol red 
Sigma-Aldrich, Germany  
Albumin from bovine serum (BSA), 
lyophilised powder, suitable for cell 
culture, ≥96% (agarose gel 
electrophoresis) 
Sigma Aldrich, Germany  
Gram’s crystal violet solution, contains 
2.3% certified crystal violet, 0.1% 
ammonium oxalate and 20% ethyl 
alcohol 
Fluka Chemie, Switzerland  
The experiments with cells were carried out in vitro with Chinese hamster 
ovary (CHO) and mouse hepatoma MH-22A (MH-22A) cell lines. 
The preparation and estimation of CHO and MH-22A cell viability were 
performed at Vytautas Magnus University (Kaunas). The experiments with SAF and 
FCS spectroscopies were performed at the University of Zurich (Switzerland). All 
the other experiments were performed at Kaunas University of Technology 
(Kaunas).  
3.2 Methods 
3.2.1 Preparation of graphene oxide 
The graphene oxide (GO) dispersion was prepared by diluting dispersion, with 
a concentration of 500 mg/l with deionised water. Before using it for the 
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experiments, the GO dispersion was sonicated for 1 hour in an ultrasonication bath 
(Branson 2510, USA). For the Raman scattering and AFM measurements a drop of 
dispersion was dropped onto glass or another substrate and it was left to dry for 1 h. 
3.2.2 The functionalisation of graphene with meso-tetra (4-sulfonatophenyl) 
porphyrins 
Coverage of the purchased high-quality CVD graphene film on Si/SiO2 
substrates was 95%. The thickness of the SiO2 layer was 285 nm. The metal-free and 
Fe (III) meso-tetra (4-sulfonatophenyl) porphyrin solutions (TPPS4 and FeTPPS4, 
respectively) (10-5 M concentration) were prepared by dissolving in deionised water 
of TPPS4 and FeTPPS4 porphine chloride powders. The reversible 
protonation/deprotonation process of metal-free TPPS4 is performed by adding HCl 
or NaOH into the stock solution and controlled by both pH measurements (pH-150 
M, Gomel Plant of Measuring Devices) and direct UV-Vis characterisation. Before 
the adsorption of porphyrins on graphene, the solutions were filtered through 200-
nm pore membrane filters, then precipitated onto the substrates by the drop-and-dry 
method (5 μl per a droplet) and rinsed for 5 min with deionised water. 
3.2.3 The functionalisation of graphene oxide with hematoporphyrin 
The GO stock dispersion was prepared by diluting 510 μl GO (500 mg/l) in 
500 μl deionized water. For the preparation of acidic solutions, a few μl of 
concentrated sulfuric acid (SA) were added to the stock dispersion of GO to reach a 
final pH value of c.a. 2.0. The hematoporphyrin solution was prepared by diluting 
500 μl HP (10-5 M concentration) in 500 μl deionized water. For acidic solutions of 
HP, conc. sulfuric acid was added to reach the pH value of the final solution of c.a. 
2.6. The reversible esterification reaction is performed by adding SA or NaOH into 
the solution and controlled by pH measurements at room temperature and direct UV-
Vis characterisation. For the Raman scattering and FT-IR measurements a drop of 
dispersion was placed on the glass substrate; in the case of Raman scattering it was 
left to dry for 1 h. 
3.2.3.1 Measurements concept and data processing algorithms 
Initial measurements were focused on the properties and aggregation state of 
single HP and GO itself under sulfuric acid treatment. Then, the interaction between 
hematoporphyrin and graphene oxide was measured at neutral pH. Finally, 
hematoporphyrin, graphene oxide and sulfuric acid interactions were investigated. In 
the last case, the reversibility of the reaction between hematoporphyrin and graphene 
oxide was controlled by UV-Vis measurements using H2SO4 and NaOH water 
solutions for pH changing. 
Measurements for different GO-HP ratios were performed in line with the 
following procedure: 1:10 diluted initial solutions of HP (10-5 M) were mixed with 
the same volume, but different concentrations of GO (500 mg/l) water solutions - 
1:2, 1:5, 1:10, 1:12.75, 1:20 (by volume). Fluorescence measurements were 
undertaken using a USB2000 fibre optic spectrometer, excited by blue laser (473 
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nm). The same measurements were also repeated for samples with the addition of 1 
μl of conc. H2SO4 (pH 2). The total emission was calculated in the following way: 
𝐼∗(𝑡) = ∑ 𝐼(𝑡)𝜆=700 𝑛𝑚𝜆=600 𝑛𝑚  (3.1) 
where I (t) is the intensity of average and background corrected luminescence 
response. 
The HP/GO ratio γ (surface/surface) within aggregates was estimated using the 
following procedure. The total surface area occupied by the HP molecules and GO 
flakes are designated as SHP and SGO, respectively. Hence, the HP/GO ratio γ might 
be described by the following expression: 
𝛾 = 𝑆𝐻𝑃
𝑆𝐺𝑂
 (3.2) 
SHP and SGO are the total surface areas occupied by the HP molecules and GO 
flakes, respectively. SGO might be easily estimated using a value of graphene oxide 
specific surface area δ specified by the producer (c.a. 833 m2/g) contrary to the same 
value of graphene in 2,630 m2/g (Zhu et al., 2010). If xGO (gram) is the total mass 
of GO in solution, the surface area covered with GO is expressed by the formula: 
𝑆𝐺𝑂 = 𝛿 ∙ 𝑥𝐺𝑂  (3. 3) 
Considering that the polar surface area of HP s is c.a. 172 Å2 and xHP (gram) is 
the total mass of hematoporphyrin in solution, the total surface occupied by the HP 
molecules in solution could be expressed as: 
𝑆𝐻𝑃 = 𝑥𝐻𝑃(𝑚𝑤𝐻𝑃 𝑁𝐴⁄ ) ∙s (3.4) 
where mwHP (gram) = 598.69 g and NA = 6.0221•1023 are the molecular weight 
of HP and Avogadro number respectively. When SHP and SGO are expressed from 
(3.2) and (3.3) equation (3.4) becomes: 
𝛾 = 𝑆𝐻𝑃
𝑆𝐺𝑂
= 𝑥𝐻𝑃
𝑥𝐺𝑂
∙
𝑠 ∙ 𝑁𝐴
𝛿 ∙ 𝑚𝑤𝐻𝑃
≈ 2 ∙ 𝑥𝐻𝑃
𝑥𝐺𝑂
 (3. 5) 
It is reasonable to stress that the value of γ (surface/surface) is slightly 
underestimated owing to the overestimation of s and underestimation of δ. 
The analysis of concentration dependences was performed in the framework of 
the competition model using the Morgan-Mercer-Flodin equation or the logistic 
curve for data in the steady-state regime (Snopok, Boltovets and Rowell, 2006): 
𝐼∗~ 1
1+( 𝛾
𝛾0
)𝑝 (3.6) 
γ~1/xGO and γ0~1/xHP, where XHP is the initial amount of the competitor (HP) 
in the solution and xGO is proportional to the total value of adsorbed capacity of 
GO. Power p represents the order of the reaction in the competitor (HP), an effective 
value indicating the mechanism of the processes occurring in the system. To 
approximate the curves and linear dependence, the nonlinear regression analysis 
procedures of OriginPro 8.5 were used. 
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3.2.4 The functionalisation of graphene oxide with meso-tetra (4-pyridyl) 
porphine 
Meso-tetra (4-pyridyl) porphine was dissolved in deionised water at room 
temperature under acidic aqueous medium (HCl was added to reach pH 2 at the 
concentration 5x10-4 M), obtaining a greenish colloid. Graphene oxide dispersion, 
with a concentration of 500 mg/l was diluted with deionised water. A suspension of 
aggregates was prepared by a simple π-π stacking approach. The pH was adjusted 
using HCl solution to reach 1.5 to 2.3 pH and 1% CaCO3 to reach a pH from 5.4 to 
9.1. In a typical experiment, GO was suspended in anionic meso-tetra (4-
sulfonatophenyl) porphine dihydrochloride aqueous solution. Measurements of the 
absorption and fluorescence spectra were carried out after mixing 5x10-4 M 
porphyrin with different concentrations of graphene oxide at room temperature 
within 1 min. For the Raman scattering and AFM measurements a drop of solution 
was placed on the glass/gold substrate and left to dry for 1 h. 
3.2.5 The functionalisation of graphene oxide with doxorubicin 
Doxorubicin (DOX) was dissolved in deionised water to obtaining a 
concentration of 0.05 μg/ml. Sonicated graphene oxide dispersion (500 mg/l) was 
diluted with deionised water to obtaining a concentration of 6.25 μg/ml and mixed 
with doxorubicin.  
For the experiments with an additionally heated mixture, the prepared 
suspension was placed in an ultrasonication bath for additional 1 hour with heating 
(~40ºC) to catalyse a covalent bonding between the GO carboxyl and DOX amino 
groups. 
3.2.6 Substrate preparation 
For the AFM, SEM and Raman measurements substrates were immersed in the 
Piranha solution for 24 h and after that rinsed a few times with deionised water. 
As support for the lipid bilayers, glass coverslips were used. The pieces (ca. 
2.5 × 4 cm) were cleaned in ethanol and sonicated for 15 min at 20°C in an 
ultrasonic bath and stored in ethanol. Before use, substrates were rinsed several 
times with deionised water, dried with nitrogen gas, affected with low pressure 
plasma (Electronic Diener) for 10 minutes and glued onto an aluminium sample cell.  
3.2.7 Preparation of bilayer lipid membrane 
Bilayer lipid membranes were prepared following a modified protocol of 
Richter et al (2003). The mixture of phospholipids: DOPS, DOPC and DOPE were 
solved in chloroform and mixed at a ratio of 35:65:0.000016. If DOPE were not 
used, the DOPS and DOPC ratio was 35:65. The lipid was dried overnight under 
vacuum to remove the solvent and then resuspended in Tris buffer (149 mM NaCl, 5 
mM CaCl2, 10 mM Tris) to a final concentration of 0.1 g/l. The resulting solution 
was extruded 27-29 times through a membrane (pore size 0.1 μm) to produce 
unilamellar vesicles. The vesicle solution was put directly in the measurement cell 
containing the glass substrate. The lipid solution was flooded with a peristaltic pump 
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for 10 min with a velocity of 0.250 ml/min, then the solution was left for 20 min so 
the vesicles could disperse on the surface, and after that it was replaced by the pure 
Tris buffer. Subsequently, this solution was exchanged again by a Ca2+ free Tris 
buffer (10 mM Tris, 133 mM NaCl) containing 5 mM EDTA in order to remove the 
Ca2+ ions and finally by PBS buffer. All buffers contained 0.05% NaN3 and were 
adjusted to pH-7.4. After 3 h of rinsing with PBS, the bilayer was ready for 
measurements with other nanoparticles. 
For the Raman measurements, bilayer lipid membranes were prepared in the 
following way: the mixture of phospholipids, DOPS and DOPC, were solved in 
chloroform and mixed at a ratio of 35:65. The lipids were dried with nitrogen gas 
and then resuspended in Tris buffer to a final concentration of 0.1 g/l. The resulting 
solution was extruded 27-29 times through a membrane (pore size 0.1 μm). The 
vesicle solution was put directly on the SERS substrate. The lipid solution was left 
for 30 min and after that it was replaced by the pure Tris buffer. Then, this solution 
was exchanged after 15 min again by a Ca2+ free Tris buffer containing 5 mM 
EDTA in order to remove the Ca2+ ions and finally, after another 15 min - by PBS 
buffer. After 1 h of rinsing with PBS, the bilayer lipid membranes were ready for 
Raman measurements. 
For the analysis of the FCS data a diffusion model expanded by a second 
diffusion coefficient in a linear combination (D, Da, Db) was used. 
𝐺(𝜏) = 𝑎 ∗ 𝐺0 ∗ �1 + 4 𝐷𝑎𝜔02𝜏 �−1 + 𝑏 ∗ 𝐺0 ∗ �1 + 4 𝐷𝑏𝜔02𝜏 �−1  (3.7) 
with  𝐷 = 𝑎 ∗ 𝐷𝑎 + 𝑏 ∗ 𝐷𝑏 (3.8) 
where G0 is the intercept of the FCS curve and inverse proportional to the 
number of the fluorescent molecules and ω0 is the radius of the detection volume.  
3.2.8 Preparation of ZnO and TiO2 suspension 
5 mg of ZnO/TiO2 powder was sonicated for 15 min at 20°C in an ultrasonic 
bath along with 50 μl of 2-propanol. Next, 5 ml of PBS was added and the 
suspension (1 mg/ml) was sonicated for 1 h at 20°C. For the higher concentration 
suspension preparation (2.5 mg/ml) 12.5 mg of ZnO/TiO2 powder was sonicated for 
15 min at 20°C in an ultrasonic bath along with 125 μl of 2-propanol and 5 ml of 
PBS was added, and the suspension was sonicated for 1 h at 20°C. The ZnO or TiO2 
suspension was filtered with a 200 nm polyethersulfone pore membrane (Chromafil 
PES-20/25, Macherey-Nagel) and placed onto the glass substrate (Carl Roth, 50 x 24 
mm) and then dried and measured. 
3.2.9 The preparation of Ag and Au SERS substrates 
The preparation of silver and gold SERS substrates was based on direct silver 
and gold ion reduction by elemental silicon. Silicon wafers were cut into small 
pieces (1.5 cm × 1.5 cm) cleaned by immersing them in pure ethanol and dried 
under nitrogen flow. Hydrofluoric acid was diluted with water to a final 
concentration of 24%. 
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Silver solution was prepared by diluting AgNO3 with water to the final 
concentration of 2.0 mM. Silicon wafers were immersed in the prepared HF solution 
for 10 s, then immediately transferred to the AgNO3 solution for 5 s, then immersed 
in water and finally dried under nitrogen flow. 
Gold solution was prepared by diluting hydrogen tetrachloroaurate (III) with 
water to a final concentration of 2.5 mM. Silicon wafers were immersed in the 
prepared HF solution for 20 s, then immediately transferred to the hydrogen 
tetrachloroaurate (III) solution for 20 s, then immersed in water and finally dried 
under nitrogen flow. 
3.2.9.1 The formation of 1-dodecanethiol binding layer on Au SERS substrate 
The modification of the Au SERS substrate was performed as follows. 3 ml 1-
dodecanethiol was diluted to 5 ml with ethanol. The prepared Au SERS were 
immersed in the solution for 2 hours. The proposed formation of the binding layer is 
shown in Fig. 3.1: 
 
Fig. 3.1. The formation of binding layer on Au SERS substrate  
3.2.10 Preparation of cell culture for experiments 
The cells were cultured in 25 cm2 tissue culture flasks in DMEM 
supplemented with 10% FBS, 1% L-glutamine, 90 μg/ml streptomycin and 100 
U/ml penicillin (complete DMEM) in a humidified atmosphere of 95% air and 5% 
CO2 at 37°C. When the cells reached confluence, they were detached from the 
bottom of the flask with 1.5 ml of 0.25% trypsin-0.02% EDTA solution. Then, the 
cell suspension was supplemented with 2.5 ml of complete DMEM, centrifuged for 
2 min at 1,000 rpm (Biosan LMC-3000, Latvia) and resuspended in 1 ml of 
complete DMEM.  
3.2.10.1 The preparation of sample and estimation of cell viability 
The 10% BSA solution was prepared by diluting BSA in 0.9% NaCl. The 
influence of GO and GO-BSA on the viability of CHO and MH-22A cells was 
evaluated by a colony formation assay (Freshney, 2005). 40 mm diameter Petri 
dishes were filled with 2 ml of complete DMEM, which was afterwards 
supplemented with the corresponding investigating materials (one of the following: 
10% BSA; 12.5, 25.0 or 50.0 µg/ml of GO; 12.5, 25.0 or 50.0 µg/ml of GO with 
10% BSA). Also, control samples (without GO and GO-BSA treatment) of CHO 
and MH-22A cells with 0.9% NaCl solution were prepared. The Petri dishes were 
incubated for 30 min under the same conditions as described above. Approximately 
300 cells per Petri dish were seeded. Then, the cells were incubated for 5 (CHO) or 
8 (MH-22A) days for the formation of colonies. After incubation the cell colonies 
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were fixed using 70% ethanol. After fixation, the cells were stained with a Gram’s 
crystal violet solution, air dried and counted through a binocular light microscope 
with 16x magnification. The viability of experimental groups was expressed as a 
percentage number of colonies compared to control (100%). Digital images of the 
colony examples were taken using a Moticam 2300 camera (Motic, Hong Kong) 
which was connected to the inverted ECLIPSE TS100 microscope (Nikon, Japan) 
with a magnification of 40x.  
3.2.10.2 The preparation of cell samples for investigation by AFM and Raman 
spectroscopy and imaging 
100 µl of the cells suspension (1x106 cells/ml) was seeded on the surface of a 
lithium niobate plate into each Petri dish filled with 2 ml of complete DMEM. The 
lithium niobate plates were selected because of good surface characteristics for cells 
growth and for the following analysis by Raman spectroscopy because of low 
background signal (Rodaite-Riseviciene et al., 2013). Then the cells were incubated 
for 24 h (CHO) or 48 h (MH-22A) to reach a confluent cell monolayer. Controls, 
without the treatment with GO, were performed in the case of both cell lines. GO 
dispersion was sonicated as described above. GO (12.5 µg/ml) was added into the 
Petri dishes with the cells for further incubation. After 24 h incubation the cells were 
washed with deionised water, fixed with 4% formaldehyde (in PBS) for 10 min at 
room temperature, washed again with deionised water and air dried. 
3.3 Analytical techniques 
In this thesis, a number of analytical techniques have been used with the aim to 
characterise the final products and to identify important experimental parameters. 
Raman spectroscopy has been used to obtain an understanding of the chemical 
composition, and atomic force microscopy giving the information about the 
morphology of the sample. Other methods applied in this work are UV-Vis, 
supercritical angle fluorescence and Fourier transform infrared spectroscopies, and 
scanning electron and light microscopies.  
3.3.1 Raman spectroscopy 
The Raman measurements were undertaken using the NTEGRA Spectra 
system (NT-MDT Inc.) in an upright configuration. The excitation wavelength was 
532 nm (20-mW DPSS laser, LCM-S-111-20-NP25) with a controlling laser power 
in the range of 0.005–5 mW. To avoid extensive heating of the sample and beam 
damage, a different laser power was used for the analysis. The instrument was 
equipped with a 100× 0.7 NA objective, resulting in a diameter spot of 0.5 μm at the 
laser focus. The beam was focused on the sample, which rests on a controlled XYZ 
piezo stage capable of scanning samples over 130 × 130 × 7 μm. The scattered light 
was collected by the same objective and directed through a 100-μm pinhole into a 
spectrometer (Solar TII, MS5004i). The signals were analysed with a TE-cooled 
(60°C) CCD (1,024 × 128 pixels, DV401- BV, Andor Technology). The diffraction 
gratings of 600 lines/mm or 1,800 lines/mm were used, resulting in a spectral 
resolution of about 2.5 cm-1 or 0.8 cm-1, respectively. Another CCD is used to collect 
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bright field images. A confocal Raman system was also used for measurements in a 
water environment. 
The Raman measurements of cells were measured as follows: The search for 
GO in the cells was performed by the estimation of the characteristic Raman 
spectrum, the series of Raman spectra were recorded consistently along the Z axis 
across the cell, starting from outside of the cell. Over 260 spectra from 24 different 
cells were evaluated, and at least 11 spectra were acquired from each cell. The 
power of the laser at the sample was 5 mW for CHO and 0.5 mW for MH-22A, 
acquisition time - 5 s. To avoid overheating, a different power of laser irradiation at 
the cells was used. The distribution of GO inside the cells and cell fingerprint 
spectra were monitored by Raman imaging. Laser power was 5 mW at the cell 
surface, acquisition time - 1 s/pixel, image resolution - 92 x 92 pixels. Hyperspectral 
image collect over 8,000 spectra from each mapping picture. The GO distribution 
inside the cells was investigated by collected spectra evaluation and GO spectra map 
building on top of the confocal optical cell image. 
3.3.2 Atomic force microscopy 
Measurements were performed using NT-MDT Solver system (NT-MDT Inc.) 
in a semi-contact mode using commercial silicon cantilevers with a tip diameter of 
10 nm and a force constant of 1.5 N/m. The AFM investigations for the ZnO and 
TiO2 nanoparticles were done using commercial silicon cantilevers NSG11 with a 
force constant of 5 N/m.  
The morphology of the supported lipid membranes was investigated by AFM 
imaging. Measurements were performed using the NT-MDT Solver system (NT-
MDT Inc.) in a semi-contact mode in solution using commercial silicon cantilevers 
with a resonant frequency of 7-20 kHz and a spring constant of 0.08 N/m. Images 
were processed and analysed with NTEGRA Spectra software. 
Cells morphology was investigated by AFM imaging and measurements of the 
cells membrane roughness. Measurements were performed for both cell lines using 
NT-MDT Solver system (NT-MDT Inc.) in a semi-contact mode using commercial 
silicon cantilevers with a tip diameter of 10 nm and force constant 1.5 N/m. Cell 
membrane roughness was measured on the topography images using SPIP™ 
software. The roughness average (SA) parameter was used for the comparison of the 
measured topographic results. Thirty surface areas of the cells (1000 × 1000 nm) 
were chosen at random from three independent experiments for CHO control cells, 
mouse hepatoma MH-22A control cells, CHO cells after the treatment with 12.5 
µg/ml of GO and mouse hepatoma MH-22A cells after the treatment with 12.5 
µg/ml of GO. 
3.3.3 Supercritical angle fluorescence spectroscopy 
SAF is a technique to detect and characterise fluorescent species (proteins, 
biomolecules, pharmaceuticals, etc.) and their behaviour very close or even adsorbed 
or linked to surfaces. The method is able to observe molecules at a distance of less 
than 100 nanometre from the surface even in the presence of high concentrations of 
fluorescent species. Using an aspheric lens for excitation of a sample with laser 
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light, fluorescence emitted by the specimen is collected above the critical angle of 
total internal reflection selectively and directed by parabolic optics onto a detector 
(Fig. 3.2). The method was invented in 1998 in the laboratories of Stefan Seeger at 
the University of Regensburg (Germany) and later at the University of Zurich 
(Switzerland) (Enderlein, Rukstuhl and Seeger, 1999). The principle on how SAF 
microscopy works is as follows. A fluorescent specimen does not emit fluorescence 
isotropically when it comes close to a surface, but approximately 70% of the 
fluorescence emitted is directed into the solid phase. Here, the main part enters the 
solid body above the critical angle. When the emitter is located just 200 nm above 
the surface, fluorescent light entering the solid body above the critical angle is 
decreased dramatically. Hence, SAF Microscopy is ideally suited to discriminating 
between molecules and particles at or close to surfaces and all other specimen 
present in the bulk (Ruckstuhl, Rankl and Seeger, 2003).  
 
Fig. 3.2. Setup of SAF microscope (Ruckstuhl, Verdes, 2004) 
Images of fluorescently labelled lipid membranes were recorded with a 
custom-made scanning microscope allowing the detection of fluorescence and the 
supercritical angle fluorescence images of an emitter simultaneously. The SAF 
channel detects only fluorophores in close proximity to the surface (∼100-200 nm) 
and efficiently rejects the fluorescence from the bulk solution using parabolic lenses 
as the decisive optical element. All measurements were conducted by passing 
buffered solutions of NP’s over the lipid membrane through the flow cell at a 
constant pump rate of 250 μl/min (0.42 mm/s) (Fig. 3.3). This flow rate is clearly 
slow enough to have no effect on the bilayer lipid membrane integrity. Raw scan 
images are presented as measured using an appropriate linear scaling for the signal 
intensities. Note that the background subtraction in all images is based on a fixed 
intensity threshold. The shown images are selected representative images from time-
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lapse experiments which were conducted at varying time intervals because the 
applied setup (non-commercial) does not contain the option of a software controlled 
time-lapse measurement.  
Fluorescence correlation spectroscopy (FCS) is a method that was introduced 
and established as a very suitable approach to characterise membranes (Bacia, 
2004). FCS was employed by several authors to measure the lateral lipid mobility 
and to assess the impact of NP’s on lipid dynamics in supported lipid membranes 
(Garcia-Saez, Carrer and Schwille, 2010; Garcia-Saez and Schwille, 2008). 
 
Fig. 3.3. Supported lipid bilayer formation on SAF microscopy  
A hardware correlator translates the photon arrival pulses into intensity 
fluctuations and calculates the correlation real-time. The correlation curves were 
acquired and fitted to analytical expressions. For an averaged correlation 
measurement, a separate correlation measurement of 100 seconds duration was 
taken, and corresponding standard deviations for every point of the experimental 
curves were calculated from multiple experiments. 
The diffusion coefficient of the lipids in the supported lipid bilayer was 
determined from the experimentally obtained correlation time and the known waist 
of the confocal observation volume.  
3.3.4 UV-Vis spectroscopy and emission spectra measurements 
The principle of ultraviolet-visible absorption is that molecules containing π-
electrons or non-bonding electrons (n-electrons) can absorb the energy in the form 
of ultraviolet or visible light to excite these electrons to higher anti-bonding 
molecular orbitals (Mehta, 2011). The more easily excited the electrons (i.e. lower 
energy gap between the HOMO and the LUMO), the longer the wavelength of light 
it can absorb. 
The absorption and emission spectra measurements were undertaken using a 
USB2000 fibre optic spectrometer (Ocean Optics). The fluorescence was excited by 
a 500 mW DPSSL laser (473 nm, LRS-476-TM-50-5, Laserglow Technologies).  
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3.3.5 Fourier transform infrared spectroscopy 
Fourier transform infrared spectroscopy (FTIR) (Griffiths, James, 2007) is a 
technique, which is used to obtain an infrared spectrum of absorption or emission of 
a solid, liquid or gas. An FTIR spectrometer simultaneously collects high spectral 
resolution data over a wide spectral range.  
The measurements of samples in a water environment with the FTIR spectra 
were performed by FTIR spectrometer Spectrum 100 (Perkin Elmer). The artefact 
level of this system is <0.005%T; a precision of ca 0.008 cm-1. Spectral range 700-
4,000 cm-1. 
3.3.6 Scanning electron microscope 
A scanning electron microscope (SEM) produces images of a sample by 
scanning it with a focused beam of electrons. The electrons interact with atoms in 
the sample, producing various signals that contain information about the sample’s 
surface topography and composition.  
The morphology and composition of the aggregates were examined using a 
SEM/Focused Ion Beam (FIB) workstation Helios Nanolab 650 with an energy 
dispersive X-ray (EDX) spectrometer INCA Energy 350 X-Max 20. 
3.3.7 Light microscopy 
Digital images of the colony examples were taken using a Moticam 2300 
camera (Motic, Hong Kong) which is connected to the inverted ECLIPSE TS100 
microscope (Nikon, Japan) with 40x or 125x magnification. 
3.4 Statistical analysis of experimental data 
The processing of the experimental data was performed by Microsoft Excel 
2010, OriginLab Corporation OriginPro 8.5, SPIP, NOVA 1.1.0.1840, MATLAB 
7.12.0, GIMP2, CrystalSleuth and ImageJ.  
The molecules were drawn using HyperChem 5.02 software and molecular 
mechanics optimisation was done by Newton- Raphson algorithm.  
Statistical analysis was performed by Student’s t-test. T-Test calculation for 
two independent means is used for comparing the averages of two separate groups. 
The null hypothesis (H0: u1 - u2 = 0, where u1 is the mean of first group and u2 the 
mean of the second) tends to be that there is no difference between the means of the 
two populations; or, more formally, that the difference is zero (for example, that 
there is no difference between the average values of two groups). The calculations of 
statistics were performed using the following equation:  
𝑡 = 𝑥1 − 𝑥2
∫ �
(𝑁1 − 1)𝑠12 + (𝑁2 − 1)𝑠22
𝑁1 + 𝑁2 − 2 � � 1𝑁1 + 1𝑁2� (3. 9) 
 
Then the p-value, a function of the observed sample results (relative to a 
statistical model), which measures how extreme the observation is, was evaluated 
(*p<0.05, **p<0.01, ***p<0.005). 
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4 RESULTS AND DISCUSSION 
4.1 The functionalisation of graphene/graphene oxide with organic molecules 
and characterisation  
4.1.1 Characterisation of graphene oxide 
The preparation of GO solution in neutral pH was carried out according to the 
procedure described in section 3.2.1. The UV-Vis measurements were performed in 
order to determine the formation of stable graphene dispersions. As shown in Fig. 
4.1, the absorption peak of the GO dispersion at 230 nm and a weak shoulder at 
~302 nm suggests that the electronic conjugation within the electronic conjugation 
level of graphene is chemically controllable, offering possibilities to tailor the 
properties of graphene sheets. Graphene sheets with different reduction levels can 
also form stable dispersions with other materials. In addition, GO is also expected to 
exhibit unique optical properties as evidenced by the recent demonstration of 
photoluminescence. This luminescence was found to occur from the near-UV-to-
blue visible to near-infrared (IR) wavelength range (Loh et al., 2010). This property 
could be useful for biosensing, fluorescence tags and optoelectronics applications. 
 
Fig. 4.1. Absorption and emission spectra of GO 
The illumination of GO samples was performed with blue laser (473 nm), so 
no near-UV-to-blue visible fluorescence was noticed, indeed, the low intensity 
luminescence within the range of 600-700 nm was induced. The shift in the 
fluorescence peaks of the suspension may be attributed to the differences of the 
surrounding medium. Pan et al. (2010) have demonstrated that the blue fluorescence 
of graphene is pH-dependent. The fluorescence is strong enough to be observable by 
the naked eye at high pH levels, while it is nearly quenched in low pH levels. The 
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explanation is that protonation of the emissive zigzag sites at acidic pH conditions 
quenches the fluorescence and deprotonation in alkaline conditions, recovers it. 
4.1.1.1 GO characterisation with AFM 
In order to explore the GO structure in more depth, microscopic techniques 
such as atomic force microscopy have been employed for the investigation of its 
structural features. AFM directly gives the apparent thickness of the single-layer GO 
(around 1 nm, fig. 4.2) as well as the number of layers. 
 
Fig. 4.2. GO characterisation by AFM. a) Height image of GO flakes b) cross section of a 
GO flake 
To prove the impact of sonification for GO solution, the following experiment 
was performed. The different samples of a) GO sample without sonification b) GO 
after 30 min sonification and c) after 1 hour sonification were prepared by putting 
the solution of GO in a sonification bath for the corresponding time, then samples 
were dropped onto the mica surface and kept for 5 min, after that spin coating was 
performed. Samples were tested with AFM and the influence of the sonification time 
was evaluated from the obtained pictures (Fig. 4.3). 
 
Fig. 4.3. GO characterisation with AFM. a) Without sonification, b) after 30 min 
sonification, c) GO after 1 hour sonification 
From the obtained AFM pictures after 1 hour sonification the small flakes of 
GO (0.3-0.7 μm) are dominant. After 30 min sonification, the middle size flakes 
(0.9-1.2 μm) are dominant. Without sonification, the big size flakes (1.2 μm and 
more) are dominant. According to the manufacturer data sheet (Graphene 
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Supermarket) the size of flake is: 0.3-0.7 microns and a thickness of 1 atomic layer - 
at least 80%. So, before all experiments with GO solution, the sonification for at 
least 1 hour is needed to recover of characteristics provided by producer.  
4.1.1.2 GO characterisation with Raman spectroscopy 
Raman spectroscopy can be used for both quantitative and qualitative 
investigations. For example, the amount of layers (single layer, bilayer, etc.) of 
graphene and the effect of substrates on the graphene characteristics, etc. can be 
determined by Raman spectroscopy. The Raman spectrum of graphene oxide shows 
the main features of the carbon materials, D ~1,334 cm-1, G ~1,559 cm-1, 2G ~3,200 
cm-1 and 2D (often also referred to as G) bands ~2,668 cm-1 (using an excitation 
wavelength of 532 nm). The G band is due to bond-stretching in rings and chains 
(Pimenta et al., 2007). The D band is caused by the breathing modes of sp2-atoms in 
rings. The D-band appears when structural disorder, e.g. impurities and edges, 
breaks the translational symmetry. The D band intensity can be correlated to the 
edges and other defects in the graphene sheet (Kudin et al., 2008). Thus, the G and 
D bands provide useful information on in-plane vibrations and defects, respectively. 
For graphite the D/G ratio has been related to the in-plane grain-size (Cancado et al., 
2006). This ratio gives a means to analyse the disorder in the graphene system. The 
2D band gives information on the stacking order and has recently been used as a 
simple and efficient way to identify single layer graphene sheets. Raman 
spectroscopy was applied to graphene single layers, bilayers, etc. by different 
researchers (Ferrari et al., 2006; Balandin et al., 2008). For single-layer graphene the 
relative intensity between the G and 2D band reverses as compared to multilayer 
flakes (Ni et al., 2008). Moreover, other nanomaterials can also be characterised 
using Raman spectroscopy.  
  
Fig. 4.4. The typical Raman spectra of GO (λex- 532 nm) 
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The typical Raman scattering spectra of the measured GO films presented in 
Fig. 4.4. The typical band regions of the in-phase vibration of the GO lattice (G and 
2G band) are at ~1,600/3,200 cm-1 and the disorder band regions caused by the GO 
edges (D and 2D band) are at ~ 1,334/2,668 cm-1. 
4.1.2 Graphene functionalisation with meso-tetra (4-sulfonatophenyl) 
porphines  
A non-covalent interaction of iron and metal-free meso-tetra (4-
sulfonatophenyl) porphines (FeTPPS4 and TPPS4) with single-layer graphene was 
investigated. The central metal atom of porphyrin macrocycle (iron) plays an 
important role in the integrity of FeTPPS4 on graphene surfaces. The interaction of 
metal-free TPPS4 with graphene leads to the deprotonation of TPPS4 molecules and 
not significant Raman enhancement values. The Raman enhancement factors were 
evaluated as a ratio of background subtracted Raman spectra of the corresponding 
films on graphene and glass multiplied by factor of 3 which is caused by the 
difference in the film thicknesses on glass (25 ± 5 nm) and graphene (8 ± 2 nm). For 
TPPS4 film (pH = 4) the enhancement factor of 4 is obtained for all peaks due to a 
strict conformity of the spectra (the deviation is ± 0.3). On the contrary, the Raman 
signals of FeTPPS on graphene are reduced by a factor of 1.5. Deprotonated TPPS4 
solutions after the adsorption on the graphene surface demonstrates the appearance 
of new Raman bands (774, 1,181, 1,653 cm-1) and enhanced Raman signals (1,363, 
1,509 cm-1) (Fig. 4.10). A strong non-covalent interaction between deprotonated 
TPPS4 and graphene is realised through pyrrole and desulphonated phenyl rings of 
closely located planar TPPS4 molecules on the graphene surface. 
4.1.2.1 UV-Vis and Raman characterisation of TPPS/FeTPPS porphyrins  
The configuration of the electron cloud of an individual porphyrin molecule 
and its absorption spectrum are very sensitive to the surrounding media due to the 
number of free anions/cations presented in the solution. The used porphyrin salts 
after dissolving in deionised water usually had an acidity of about pH 4. The metal-
free TPPS molecules in water solution at pH 4 are diprotonated (Goncalves et al., 
2005). The deprotonation process of TPPS molecules in aqueous solution (10-5 M) 
was performed by adding NaOH and checked by UV-Vis spectroscopy. The FeTPPS 
absorption spectrum does not change in the acidity range of 4.0-6.0. The 
corresponding UV-Vis spectra of as-prepared diprotonated (pH 4), deprotonated (pH 
6) TPPS solutions and FeTPPS at pH 4 are shown in Fig. 4.5.  
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Fig. 4.5. Normalised absorption spectra of diprotonated TPPS (pH 4, green), non-protonated 
TPPS (pH 6, red) and FeTPPS (pH 4, brown) aqueous solutions (10 -5 M) (λex- 532 nm) 
The absorption spectrum of non-protonated TPPS aqueous solution (pH 6) 
consists of an intense Soret band at 413 nm, caused by the excitation of the 
porphyrin macrocycle, and four weak Q bands centred at 516, 553, 583 and 635 nm. 
With a protonation (pH 4) a Soret band is red-shifted to 435 nm, and only three 
bands are observed in the region of the Q bands: an intense band at 645 nm and 
weaker bands at 597 and 550 nm. The acidity of porphyrin solutions was controlled 
and kept at pH 4 or 6 to avoid any possible formation of TPPS J and H-aggregates 
and non-stable monoprotonated states in the range of pH 5.0–5.5 (Kelbauskas et 
al.,2003; Rotomskis et al. 2004; Mchale, 2012). As typical for metalloporphyrins 
(Horvath et al., 2006), a Soret band of FeTPPS is blue-shifted to 394 nm and a wide 
band appears centred at 530 nm (Goncalves et al., 2008; Gandini, Yushmanov and 
Tabak, 2001).  
The influence of pH and a central metal atom to the configurations of TPPS 
and FeTPPS molecules in aqueous solutions are proposed in Fig. 4.6.  
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Fig. 4.6. The proposed molecular configurations of TPPS and FeTPPS at different pH are 
drawn using HyperChem 5.02 software 
The measured Raman spectra of TPPS and FeTPPS films deposited on the 
glass substrates from aqueous solution are shown in Fig. 4.7. The TPPS (pH 4) 
mode at 1,477 cm-1 can be assigned to the in-plane motion of the phenyl ring 
(Friedsen et al., 2009). This mode disappears in the free base as a result of the 
almost perpendicular orientation of the phenyl rings. These configuration changes 
also lead to a downshift of the out-of-plane motion of the porphyrin core to 311 cm-
1, downshift of totally symmetric pyrrole breathing vibrations from 987 and 1,017 
cm-1 to 964 and 1,002 cm-1; upshift of phenyl deformation vibrations to 718 cm-1 and 
an upshift of Cb-Cb stretch from 1,539 to 1,548 cm-1 after deprotonation is in line 
with the ‘rule of protonation’ for stretching vibrations (Akins, Zhu and Guo, 1996). 
These configuration changes also lead to the significant enhancement of pyrrole 
modes at 810, 1,330 and 1,363 cm-1, Cb-H bending deformations at 1,089 and 1,144 
cm-1 and a Cm-phenyl stretching mode at 1,239 cm-1 (see Table 4.1).  
 
Fig. 4.7. Normalised Raman spectra of diprotonated TPPS (pH 4), non-protonated TPPS (pH 
6) and FeTPPS (pH 4) films formed onto the glass substrates (λex- 532 nm) 
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Table 4.1. The assignment of Raman bands of TPPS 
The mode explanation TPPS (pH 4) Changes in TPPS (pH 6) 
Out-of-plane motion of the 
porphyrin core 
316 cm-1 Downshift to 311 cm-1 
Phenyl deformation 
vibrations 
704 cm-1 Upshift to 718 cm-1 
Symmetric pyrrole 
breathing vibrations 
987 and 1,017 cm-1 Downshift to 964 and 1,002cm-1 
Pyrrole modes 810, 1,330 and 1,363 
cm-1 
Enhanced peaks 
Cb-H bending deformations 1,089 and 1,144 cm-1 Enhanced peaks 
Cm-phenyl stretching mode 1,239 cm-1 Enhanced peak 
Phenyl ring motion 1,477 cm-1 Disappears 
Cb-Cb stretch 1,539 cm-1 Upshift to 1,548 cm-1 
 
Because the Raman spectra of FeTPPS spectrum is not being changed in the 
acidity range of pH 4–6 so only the single spectrum of FeTPPS film (pH 4) is 
shown. In the case of FeTPPS film, an iron atom could be a cause of another feature 
in the difference spectrum centred at 420 and 1,362 cm-1, corresponding to the 
observed increase of Fe-O-Fe stretching vibrations. The disappearance of the mode 
at 1,477 cm-1 indicates a rotation of the phenyl rings and on a less protonated state of 
FeTPPS when the film is formed. The broad peak at 314 cm-1 is relative to the 
motion of the porphyrin core, and allows the assumption that FeTPPS molecules are 
strongly deformed after the formation of film.  
4.1.2.2 Characterisation of porphyrin films on CVD graphene 
To investigate the graphene impact on porphyrins, the measurements with 
Raman spectroscopy were performed. The Raman spectrum of a non-protonated 
TPPS after an interaction with graphene strongly correlated with the one of the film 
formed on glass substrate (Fig. 4.8 and Fig. 4.9). Whereas in the case of purchased 
CVD graphene, which was on a Si surface, during measurements an intensive Si 
band on 521 cm-1 and second, non-so intensive band around 1,000 cm-1 was visible 
(Fig. 4.8). 
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Fig. 4.8. The normalised Raman spectra of a) TPPS and b) FeTPPS on glass and graphene 
surface (λex- 532 nm) 
While non-protonated TPPS is adsorbed on graphene, its Raman spectrum 
differs from the non-protonated film on glass. There is a redistribution in the peak 
intensities, a significant enhancement of peaks (1,363, 1,509 cm-1), and even an 
appearance of new peaks (774, 1,181, 1,653 cm-1) (Fig. 4.8). The sensitive to the 
protonation ν2 Cb-Cb stretching mode at 1,548 cm-1 is not shifted, but ν11 Cb-Cb 
stretching mode at 1,510 cm-1 is upshifted and enhanced. Another enhanced band at 
1,365 cm-1 can be assigned to pyrrole vibrations which also involve the Cb atom. The 
mechanism of Raman enhancement on graphene is usually explained by the charge-
transfer phenomenon (Huang et al., 2012) by analogy with the chemical 
enhancement mechanism in ‘classic’ SERS, when an electronic coupling between 
molecules and metal substrate occurs. The peak at 1,184 cm-1 can be a Raman 
fingerprint of symmetric phenyl vibrations of desulphonated TPPS, TPP (Saini, 
2006), and should be considered with a rising peak at 1,575 cm-1 assigned to phenyl 
C=C stretch. It was shown in that the p-sulphonation of TPP phenyl groups causes a 
weakening of the peak at 1,575 cm-1, and it disappears for TPPS and vice versa, it’s 
strengthening could be evidence of the desulphonation of phenyl rings of non-
protonated TPPS. Two other bands, arising at 780 and 1,650 cm-1, can be assigned to 
significantly enhanced pyrrole vibrations (Griffiths and Chalmers, 2002; Blom et al., 
1986).  
After interaction of FeTPPS macrocycle with graphene, there were no changes 
in the peaks, which are related to the vibrations of an iron atom- 417 and 1,364 cm-1. 
The Cb-Cb stretching vibration of FeTPPS on the glass surface at 1,550 cm-1 is more 
upshifted, implying a less protonated condition of FeTPPS molecule on graphene. 
The relative increase of the Cm- phenyl (1,236 cm-1) and Cb-Cb (1,499 cm-1) 
stretching vibrations together with a significant decrease of the vibrations involving 
an iron atom (417 and 889 cm-1) correspond to the strong deformation of FeTPPS 
core after an interaction with graphene and a structural disorder of the film. In the 
case of both TPPS and FeTPPS a weak Raman signal at 1,477 cm-1 indicates that the 
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phenyl rings are perpendicular to the porphyrin core as shown in Fig. 4.11 (Buchner, 
2010).  
 
 
Fig. 4.9. The Raman spectra of TPPS film on CVD graphene in different places (λex- 532 
nm) 
The measured thicknesses of uniform films of the different porphyrin solutions 
adsorbed on chemical vapour deposition (CVD) graphene were typically less than 10 
nm (see Fig. 4.10). 
 
Fig. 4.10. The bright, confocal and AFM images of TPPS film formed on CVD graphene 
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4.1.2.3 Conclusions 
The protonation of porphyrin macrocycle or the existence of a central metal 
atom for the TPPS family plays an important role in the molecular conformation and 
orientation when interacting with single-layer graphene (see Fig. 4.11). The 
interaction of diprotonated metal-free TPPS with graphene leads to the 
deprotonation process of the porphyrin macrocycle. The downshifts of G and 2D 
Raman peaks of graphene after an interaction directly imply a charge transfer from 
TPPS molecules to graphene resulting in the electron doping of graphene, but the 
Raman enhancement factors are relatively low. The existence of a central metal 
atom in the porphyrin macrocycle (iron) is important in the integrity of the FeTPPS 
molecule during an interaction, but results in the decreased Raman signals in spite of 
the observed charge transfer effect. Initially deprotonated TPPS undergoes the 
atomic changes after an interaction with graphene, which leads to the appearance of 
new Raman bands and at least one order of magnitude higher enhancement factor for 
some pyrrole modes. The proposed explanation of enhancement is that a strong 
interaction is realised through the pyrrole and planar desulphonated phenyl rings of a 
closely located TPPS molecule on a single-layer graphene surface. A variety in the 
central metal atom of porphyrin macrocycle or its protonation opens wide 
opportunities for the fabrication of novel composite graphene-porphyrin 
nanomaterials with predetermined properties.  
 
 
Fig. 4.11. The configurations of TPPS and FeTPPS molecules in aqueous solutions and when 
adsorbed onto graphene (right) 
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4.1.3 Graphene oxide functionalisation with hematoporphyrin 
A covalent interaction of hematoporphyrin (HP) with functionalised graphene- 
graphene oxide was investigated. A combination of optical techniques, as UV-Vis 
absorption, luminescence properties and Raman scattering, can be efficiently used to 
detect an interfacial structure of hematoporphyrin/graphene oxide (HP/GO) 
nanoensembles. The stable in aqueous media at neutral pH HP/GO nanocomposites 
were obtained as a result of the esterification reaction catalysed by sulfuric acid 
(SA). The nanocomposite with stronger absorption and emission represents a 
layered structure composed of hematoporphyrin oligomers adsorbed on the surface 
of GO in a monolayer through covalent, electrostatic and p-stacking interactions. 
The formation of such hybrid structures, where graphene oxide plays a role of a non-
toxic sheet-like nanocarrier, opens the way to create a functional nanocomposite 
with a high-level of selective emission and efficient photosensitising ability using 
unique graphene properties. 
4.1.3.1 Characterisation of hematoporphyrin 
The configuration of an electron cloud of hematoporphyrin and its absorption 
spectrum also depends on the surrounding media. The HP after dissolving in 
deionised water had an acidity of about pH 7. Under neutral conditions (pH~7), 
carboxyl groups of hematoporphyrin are mainly deprotonated and become 
negatively charged; oppositely charged carboxyl croups and amino groups stimulate 
aggregation of hematoporphyrin molecules (Marchetti and Errazu, 2008) (Fig. 4.12). 
The pH changing process of HP molecules in aqueous solution was performed by 
adding H2SO4 or NaOH and controlling by UV-Vis spectroscopy.  
 
Fig. 4.12. The changes of hematoporphyrin under acidic and neutral pH level 
Absorption and emission spectra of hematoporphyrin are presented in Fig. 
4.13. The data in Table 4.2 showed that treatment with sulfuric acid essentially 
changes both the absorption and emission spectra of HP. The specific features of a 
strong Soret band (position, narrow half-width, strong vibronic coupling, etc.) 
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indicates that at pH~2 a monomer form of HP dominates in the solution. The 
hypochromic (blue) shift, wide and less intensive absorption bands indicate the 
aggregation of HP in the aqueous solution at neutral pH~7. The emission spectra of 
HP at pH~7 show typical fluorescence peaks on 616 nm and 676 nm; after adding 
sulfuric acid we observed the change of the spectrum with a main peak at 655 nm. 
Table 4.2. Absorption and emission range/peaks  
 Absorption 
range, nm 
Main 
absorption 
peaks, nm 
Emission 
range, nm 
Main 
emission 
peaks, nm 
Interpretation 
pH~2 220-585 381, 399, 
550 
585-750 623, 652, 671 Monomer form 
pH~7 367, 390 616, 674 Aggregate form 
The observed features are in good agreement with the model that sulfuric acid 
reduces aggregation of HP and shifts the equilibrium to the monomer form. Under 
neutral conditions (pH~7), carboxyl groups are mainly deprotonated (the pKa of 
carboxyl groups are mainly in the range 4-5), and become negatively charged; 
oppositely charged carboxyl groups and amino groups stimulate the aggregation of 
hematoporphyrin molecules. Sulfuric acid changes the pH below pKa disturbing 
electrostatic interactions and leads to the disaggregation of HP aggregate. 
 
Fig. 4.13. Absorption and emission spectra of hematoporphyrin with and without sulfuric 
acid, respectively 
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The influence of acidity on the optical spectra of HP is a good example of the 
processes where intermolecular coupling driven by long-range electronic 
interactions induce reciprocal polarisation of molecules or charge transfer between 
the molecules within aggregate (Fig. 4.14). Observed absorption and emission 
changes are due to the disaggregation of HP’s clusters (with main fraction of face-
to-face dimers) as a result of the change in the distribution of charge within the HP 
molecule. Indeed, with the decreasing pH tendency to charge both the central ring 
(pKa 4.9) and the peripheral substituent’s (pKa of carboxyl groups are mainly in the 
range 4-5) increases result (for pH less than c.a. 4) in positively and negatively 
charged central and peripheral parts of HP correspondingly. 
Fig. 4.14. The influence of acidity on the absorption spectra of HP; under pH 7 - after adding 
SA pH 2 - after adding NaOH into the previous solution to reach pH 7  
Consequently, at acidic pH (c.a. 2) HP exist in solution preferably in the 
monomolecular form owing to electrostatic repulsion. The process is completely 
reversible within the pH range from 2 to 7; the data obtained for this process with 
hydrochloric and nitric acid supports this model (Fig. 4.15). However, in the case of 
SA achieving reversibility is possible only at much higher pH values in the alkaline 
area (approx. pH 10). This feature is due to the esterification reaction catalysed by 
SA, resulting in the formation of linkages between separate molecules HP. More 
information can be found in the literature (Dougherty, Potter and Weishaupt, 1989). 
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Fig. 4.15. HP absorption spectra changes after adding different types of acids 
4.1.3.2 Graphene oxide absorption and emission changes under sulfuric acid 
treatment 
The absorption spectrum of GO solution in water ranging from 200 to 800 nm 
shows a main peak at ~230 nm and a weak shoulder peak at ~302 nm (Shang et al., 
2012). Typical GO absorption spectra in deionized water are presented in Fig. 4.16. 
The addition of SA had no significant influence on GO absorption spectra. 
Excitation with a blue laser (473 nm) shows low luminescence within the range of 
600-700 nm. Owing to the low absorption and emission efficiency as well as 
structureless spectra of GO within the visible region, only small changes in optical 
spectra were observed when SA was added to the GO solution.  
 
Fig. 4.16. Absorption spectra of GO and emission spectra of GO with and without SA 
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Within one hour after adding SA some visible macroscopic aggregation within 
GO solutions may be seen with the naked eye. Typical Raman scattering spectra of 
the GO films treated with and without SA are presented in Fig. 4.17 within the 
regions of the in-phase vibration of the GO lattice (G/2G band) at c.a. 1,600/3,200 
cm-1 and the disorder band caused by the GO edges (D/2D band) at approximately 
1,334/2,668 cm-1. The decreasing of D/G ratio at low pH as well as G band shift to 
the high energy indicates the decreasing of the defects and formation of more 
ordered structure (Kudin et al., 2008). 
 
Fig. 4.17. The typical Raman spectra of GO treated with SA (λex- 532 nm) 
4.1.3.3 The interaction between GO and HP 
The interaction between GO and HP were analysed by UV-Vis and Raman 
spectroscopy, FTIR. In Fig. 4.18 typical absorption and emission spectra of HP 
mixed with GO at neutral pH is presented. After addition of GO, the Soret band of 
HP undergoes a bathochromic shift from 381 to 388 nm; strong quenching of 
fluorescence and formation of macroscopic aggregates in solutions were also 
observed. All those features can be explained by the formation of HP~GO 
aggregates. 
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Fig. 4.18. Absorption and emission spectra of HP at neutral pH with and without GO, 
respectively 
Weak HP peaks on 1,343 and 1,595 cm-1 could be observed. The Substituted 
phenyl ring of HP shows at 1,595 cm-1 (Gao et al., 2013). The band at 1,343 cm-1 can 
be detected in the region of the oxidation state marker band. Graphene oxide has a 
couple of Raman-active bands visible in the spectra (Fig. 4.19), the in-phase 
vibration of the graphene oxide lattice (G band) at 1,596 cm-1 as well as the disorder 
band caused by the graphene oxide edges (D band) at approximately 1,334 cm-1. The 
hydroxyl groups yield a series of bands around 1,300-1,370 cm-1. The observed 
decrease in amplitude could be caused by the decreasing number of free hydroxyl 
groups, and the shift to 1,342 cm-1 could be caused by the appearance of a different 
type of groups ester links. The G band shifts from 1,596 to 1,594 cm-1 could also be 
partially responsible for the higher G band frequencies if significant unmodified 
graphene oxide areas remain. The addition of epoxy and hydroxyl groups is a 
broadening of the G band (Kudin et al., 2008). Raman spectra of GO coupled to the 
porphyrin fragment show spectral features which can also be recognised in the 
spectrum such as the band at 1,342 cm−1 attributed to the porphyrin fragment. The 
experiments by Silvia Giordani et al. (2009) show that after connection with 
porphyrin in the spectrum the porphyrin fragments can be recognised. Also, the 
noticeable aggregates can be observed only in solution with GO and HP treated with 
SA. The possible explanation is that sulfuric acid was a catalyst for the connection 
between GO and HP: 
 
HP-COOH + GO-OH         conc. H2SO4              HP-COO-GO + H20 (4.1) 
 
                  72 
 
 
Fig. 4.19. Raman spectra of GO, HP and GO with HP with and without SA (λex- 532 nm) 
To clarify the nature of GO~HP interactions and to indicate the reduction of 
oxygen-containing groups of GO, FTIR spectroscopy was used. FTIR spectra of the 
samples are presented in Fig. 4.20. Results show that under SA treatment the 
intensity of the bands specific for both carboxyl and hydroxyl groups are 
considerably decreased (Su et al., 2012). Fig. 4.20 shows the characteristic bands of 
GO and HP around 892 cm-1 (C-H deformation vibration of GO plane surface), 
1,066 cm-1 for C-O (ν (alkoxy)), 1,066 cm-1 for C-O (ν(epoxy)) 1,394 cm-1 for O-H 
(ν (carboxyl)) and C-N vibrations (from HP), also because of the methylene group 
(from HP), 1,634 cm-1 for C=O (carboxyl), c.a. 3,200-3,300 cm-1 for O-H of 
intercalated water and c.a. 3,668 cm-1 for OH (from GO and HP) also NH (from HP) 
vibrations. After the interaction with HP, the absorption bands of both C=O and O-H 
are considerably decreased. The results imply that most of the oxygen-containing 
groups of GO were decreased by the interaction with HP. So, the FTIR spectroscopy 
indicate the reduction of oxygen-containing groups of GO and is in good agreement 
with the assumption of GO~HP bonding as the result of the esterification reaction 
catalysed by SA. 
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Fig. 4.20. FTIR spectra of mixture of GO and HP treated with SA and without SA 
To evaluate the spatial organisation and stoichiometry of GO~HP aggregates, 
optical measurements with serially increased concentrations of GO in the mixture 
(Fig. 4.22) were performed. Total emission intensity of the HP/GO mixture depends 
on the GO~HP nanocomposite fraction where GO quench HP emissions. Analysis of 
the data presented in Fig. 4.22 shows that at the neutral pH full quenching of the HP 
emission was achieved at HP/GO (surface/surface) ratio ~c.a. 4; it corresponds to 
the situation when both sides of the GO flake were covered by a bilayer of HP 
molecules. 
At acidic pH, reached by SA full quenching reached at HP/GO ration c.a. 2 
that corresponds to the situation when each side of a GO flake is covered by a 
monolayer of HP molecules (Fig. 4.21).  
 
Fig. 4.21. Possible structural composition of graphene oxide flake covered by HP molecules  
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Nonlinear regression analysis of the experimental data (using logistic curve 
functions (3.6)) was performed and presented in Fig. 4.22 to support conclusion that 
at acidic pH a GO flake is covered by a monolayer of HP molecules. Assuming that 
the limiting surface area of HP molecules immobilised on GO is similar for both pH 
levels, the obtained difference in γ0 (21.4 and 9.1 at pH 7 and 2, correspondingly) 
may be explained by “increasing the concentration” of competitor (HP) at pH 2. So, 
taking into account that the HP/GO ratio calculated in the surface/surface values, the 
two times smaller value of γ0 at pH 2 may be explained by dissociation of HP dimers 
and differences in the composition of GO~HP aggregates at pH 2 and 7.  
 
Fig. 4.22. GO induced quenching of HP emission versus HP/GO ratio γ at neutral and acidic 
pH 
The calculated values of power p (function (3.6) which represents the order of 
the reaction in the competitor (HP) also depend on the pH. The larger the parameter 
p, the greater the degree to which the parallel processes of binding of the analyte 
(HP) with multidentate carrier (GO) occur. Keeping in mind that HP may either be 
adsorbed (without emission quenched by GO) or free moving with specific emission 
in solution, power p is the effective order of the interfacial reaction with respect to 
the HP at the surface of GO. The obtained increased p at low pH (3.4 versus 2.3 for 
pH 2 and 7, correspondingly) is in agreement with the model assuming dissociation 
of HP’s dimers at low pH and increasing the number of parallel binding of the HP 
molecules by different centres on the GO surface. 
To clarify the formation of GO~HP composites, the SEM measurement was 
performed. The SEM picture of the sample is presented in Fig. 4.23. Results show 
that under SA treatment the two types of composites could be formed: the GO flake 
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covered with porphyrins mainly in corners (Fig. 4.23, a) and the GO flake fully 
covered with porphyrin molecules (Fig. 4.23, b).  
 
Fig. 4.23. SEM picture of composites based GO and HP under the SA treatment 
 
The energy dispersive X-Ray spectroscopy (EDX) analysis (Fig. 4.23) 
confirmed the suggestions showing that spectrum 1 indicates the Si surface, whereas 
spectrum 2 indicates the carbon-based layer and the second layer (spectrum 3) is 
from porphyrin (see Table 4.3). So, the EDX results suggest that the obtained few 
layer structures was formed from “base” graphene oxide and “top” formed from 
porphyrins. 
Table 4.3. EDX analysis of composites based GO and HP under the SA treatment 
Results in atomic % C N O Na Si S 
Spectrum 1 5.83 1.16 2.39 0.08 90.19 0.35 
Spectrum 2 15.09 1.84 5.14 0.09 76.77 1.07 
Spectrum 3 27.67 10.48 45.09 2.56 3.01 11.19 
 
a) 
b) 
1 
2 
3 
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On the basis of the experimental observations of typical absorption, emission, 
FTIR and Raman scattering spectra, a plausible interpretation could be proposed for 
the driven forces of the induced reactions, final products and processes of their 
formation as schematically illustrated in the scheme (Fig. 4.24).  
 
Fig. 4.24. The schematic diagram of the core processes illustrating the diversity of the 
supramolecular architectures formed by HP and GO at neutral pH and under SA treatment a) 
as the results of esterification reaction catalysed by SA single HP molecules form oligomers 
b) GO under SA treatment decreases the number of internal defects located on the perimeter 
of the flakes; reduced GO acquire the ability to form more ordered structures, which are 
similar to the nanostructured graphite c) HP molecules are captured by GO flakes, leading to 
the formation of GO~HP/GO complex with bilayer (pH 7) and monolayer (pH 2) of HP 
molecules d) adding SA into an aqueous dispersion of HP and GO supramolecular 
nanocomposites could also be assembled with intercalated layers of HP molecules between 
GO 2D sheets 
 
The influences of acidity on the processes involving GO differs from those 
that occur for HP. Geometrically GO could be figured as a graphene fragment, 
whose edge is mainly decorated with carbonyl and carboxyl groups and base plane 
with epoxide and hydroxyl groups. Due to the large amount of oxygen containing 
defect sites on the base plane GO does not aggregate at neutral pH. Under SA 
treatment the number of internal defects (oxygen-containing groups) located 
preferably on the perimeter of the individual flakes decreases (Chen, Yan, 2010,). 
This endows GO flakes with amphiphilicity, where the periphery is inclined to the 
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hydrophilic, while the centre is hydrophobic. As a result of this modification 
amphiphilic flakes of partly reduced GO acquire the ability to form ordered 
structures with densely packed central part surrounded by hydrophilic edges directed 
to the aqueous environment, which are similar to the nanostructured graphite. 
Raman scattering measurements confirm this conclusion (Fig. 4.17). D and G bands 
are broadened, shifted to lower energies and the band at 2,350 cm-1 starts to 
dominate within the low-energy region of the spectrum. According to the 
manufacturer data sheet this band is specific for the nanocrystalline graphite 
produced by the same method as GO. 
Upon the introduction of HP molecules into an aqueous dispersion of GO at 
neutral pH, HP molecules are captured by the 2D GO’s flakes, leading to the 
formation of GO~HP complex, which is driven by the π-π staking interactions 
between the locally distributed poly-aromatic ring of GO nanosheets and flattened 
HP molecules (in the form of face-to-face dimers). It is reasonable to assume 
(Hambright, Smith, 1975) that in these complexes HP molecules adopt a coplanar 
conformation, so, even weak adhesion between two-dimensional solids may perturb 
their optical properties owing to their low dimensionality. Similar to GO, rigid 
porphyrin structures have 2D delocalised 18 π-electron conjugated electron systems 
that induces their inclination to stacking through π-π interactions and prospective 
electron-transfer ability. In line with the reported data, the non-covalent action of 
graphene with various organic molecules is realised through π-π stacking, 
electrostatic interaction and hydrogen bonding (Yang et al., 2011). Molecular 
dynamic simulation (Nicolai et al., 2013) of GO based nanocomposite shows that 
the microscopic mechanism of interactions mainly arises from the sp2 hybridised π-
conjugated structured of GO and HP, which engenders π-π interaction. It was found 
that as the result of the mixing of GO and HP UV-Vis spectrum of conjugate shows 
the characteristic red shift of the π-π Soret band from 381 nm to 388 nm. This shift 
implies that the energy gap between the ground and exited orbitals of HP in 
nanocomposite is decreasing owing to the interactions between GO and HP 
compared with single HP.  
A strong fluorescence quenching of the HP in the presence of GO indicate that 
efficient charge or energy transfer occurred from the excited state of the porphyrin to 
GO. The efficiency of fluorescence quenching of HP in the GO~HP ensemble was 
investigated by using consecutive measurements with increasing concentrations of 
GO, suggesting that electron/energy-transfer phenomena occur within the 
nanoensemble. With an increase of the GO concentrations, the aggregation of HP in 
GO~HP is also increased, and for the HP/GO ratio in c.a. 4 (surface/surface) full 
fading of the luminescence intensity of GO~HP was achieved. 
This finding is due to the formation of stable aggregates where HP in dimer 
form fully covers both sides of the GO flakes (scheme, Fig. 4.24). 
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Fig. 4.25. The influence of acidity on spectra of HP with GO; under pH 7, after SA adding 
(pH 2) and after adding NaOH to reach pH 7 
The addition of SA into an aqueous dispersion of HP and GO induces the 
formation of layered supramolecular nanocomposites (Fig. 4.25). Similar to 
measurements at normal pH consecutive measurements at acidic pH shows that, as 
the concentration of HP increase, HP monomers approaching the GO tend to parallel 
to the GO surface; the 2D GO nanosheets with decreased intra-basal defects play an 
important role in this kind of GO-assisted self-assembling. The formation of 
nanographite is not observed, the suppression of luminescence HP is much less 
effective in respect of the situation at normal pH, a similar level of suppression 
observed at approximately double the concentration of GO (or half the concentration 
of HP). So, it is reasonable to conclude that porphyrins adsorb on the surface of GO 
in a monolayer through electrostatic and π–stacking interactions with the ensuing 
organisation into 2D layered 3D stacks. It is interesting that there are no shifts of HP 
absorption bands within GO~HP complexes at low pH. Indeed, the spectral shift of 
the Soret band induced by GO~HP interactions under SA treatment is negligible 
compared to HP-GO aggregates at neutral pH (c.a.7.2). This observation can be 
explained by the fact that at normal pH GO induces some distortion of electronic 
structure of HP dimer pairs whereas at acidic pH stacking interactions between GO 
nanosheets compensate for the electronic influence on the intercalated monolayer of 
HP molecules. 
The stability of the GO~HP nanocomposite formed at acidic pH under SA 
treatment is sufficiently high in respect to one formed at neutral pH, the 
nanocomposite specific spectra was stable at least 2 h after the pH change from 
acidic to normal values. This also shows that there are additional chemical bonds 
between the GO flakes and HP, and the interaction between them is not only a 
physical adsorption. The short discussion presented above enables us to conclude 
that not only do strong π-π interactions occur efficiently between GO and HP in the 
areas of spatial stacking, but additional chemical bonds form between GO and HP 
under SA treatment. The formation of such hybrid structures, where GO plays the 
role of a non-toxic sheet-like nanocarrier, opens the way to create functional 
nanocomposites with a high level of selective emission and efficient photosensitisers 
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(for PDT) utilising unique graphene properties as a singlet oxygen generation 
enhancer (Tian et al., 2011; Wojtoniszak, 2013). 
4.1.3.4 Conclusions 
In this work absorption, emission, FTIR and Raman scattering spectroscopy, 
and SEM are employed to investigate the supramolecular architectures of HP on GO 
with the intention to understand the nature of the GO~HP interactions under SA 
treatment. It was found that under SA treatment GO essentially changes the 
monomer-dimer equilibrium of HP molecules and captures the HP molecules on the 
flake’s surface in the monolayer form with higher luminescence intensity. Finally, 
stable at neutral pH GO~HP nanocomposite were synthesised. The obtained results 
validated the concept of using esterification reactions for the formation of GO~HP 
ensembles that signified the importance of graphene as a nanoscale carrier for new 
functional materials with advanced properties. 
4.2 Synthesis of supramolecular structures using graphene oxide  
4.2.1 Graphene oxide functionalisation with doxorubicin 
A covalent interaction of GO with anticancer drug doxorubicin (DOX) was 
investigated. The nano- and microcomposites composed of doxorubicin adsorbed on 
the surface of GO through covalent and non-covalent interactions such electrostatic 
and π-π stacking interactions. The formation of such hybrid and three-dimensional 
structures open the way to create a functional nano- and microcomposite, where 
graphene oxide plays a role of a non-toxic nanocarrier and of a substance which 
enhances the anticancer effect. 
The functionalisation process of GO with DOX were determined by UV-Vis 
spectrophotometer, Raman spectroscopy and atomic force microscopy. DOX was 
covalently attached on carboxylated GO by the covalently linkage of the carboxyl 
group with the amino group, with heating and ultrasonification for one hour to 
accelerate the reaction (GO/DOX). The reaction is showed below: 
R-COOH + HN(R′)2                 R-COO
- + H2N+(R′)2       heat           R-CO-N(R′)2 (4.2) 
4.2.1.1 UV-Vis and Raman characterisation of GO/DOX 
As shown in Fig. 4.26  the doxorubicin (20 μg/ml) has a peak of plasmon 
absorbance at 488 nm (Huang et al., 2013). While when the concentration of DOX 
was only 2 μg/ml - no peak was observed, nor in mix with the GO. The UV-Vis 
spectra of GO show the main peak at 252 nm due to the C=C bond in an aromatic 
ring, the red-shift of the absorption is due to the deoxygenation reaction, whereas the 
broad shoulder peak at 302 nm can be assigned to C=O. The absorption over 302 nm 
is expected to be caused by the conjugated fused ring plane (Zhang et al., 2014). 
Shaoling Wu (2013) studied absorption properties of doxorubicin onto graphene 
oxide: equilibrium, kinetic and thermodynamic. The thermodynamic studies indicate 
that the adsorption of DOX on GO is spontaneous and endothermic in nature. 
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Fig. 4.26. The absorption spectra of GO, DOX, mixed GO+DOX and GO/DOX 
When DOX was covalently conjugated on GO, the absorption peak of 
GO/DOX is shifted to 260 nm. As to the fluorescence spectra (Fig. 4.27), GO and 
DOX (GO+DOX) mix have the fluorescence peak on 643 nm as free DOX, though 
the fluorescent intensity diminished due to the quenching effect of GO. These 
optical results indicated that DOX had been loaded on the GO based nanocarrier as 
expected (Huang et al., 2013). After the heating and mixing (when DOX was 
covalently attached to GO) of this solution a bathochromic shift was observed, - the 
main peak shifted to 647 nm. The fluorescent spectrum results also indicate that a 
strong π-π stacking interaction exists between GO and DOX (Yang et al., 2008). 
 
Fig. 4.27. The fluorescence spectra of DOX, mixed GO+DOX and GO/DOX  
Graphene oxide has a couple of Raman-active bands on the in-phase vibration 
of the graphene oxide lattice (G band) as well as the disorder band caused by the 
graphene oxide edges (D band). The visible decrease in amplitude could be caused 
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by decreasing the number of free hydroxyl groups after mixing with DOX. The shift 
to 1,351 cm-1 and increasing in amplitude after covalent binding of DOX may be 
caused by the appearance of different type of groups, the amide linkage and 
increasing number of defects on graphene oxide lattice. The G band shift from 1,589 
to 1,594 cm-1 indicates the deformation of ordered structure. The appearance of new 
peaks, the 1,500 cm-1 indicates the stretching vibration of C-N (Hannemann and 
Seiler, 2009) bond and two peaks 1,737 and 1,786 cm-1, the stretching vibrations of 
the C=O bond (Fig. 4.28).   
 
Fig. 4.28. The Raman spectra of GO, mixed GO+DOX and GO/DOX (λex- 532 nm) 
4.2.1.2 AFM and SEM characterisation of GO/DOX 
To clarify the formation of GO/DOX composites AFM and SEM 
measurements was performed. The AFM picture showed the possible formation of 
GO/DOX filaments (Fig. 4.29).  
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Fig. 4.29. The height picture of GO/DOX aggregate 
SEM measurements confirmed the formation of different sizes of filaments. 
The diameter of big filaments is around 15-20 μm (Fig. 4.30, a) and the middle size 
filaments are around 5-10 μm (Fig. 4.30, b). The dimensions of the “new-born” are 
about 1 μm diameter, and 2-3 μm length (Fig. 4.30, c).  
 
Fig. 4.30. The SEM pictures of different size of GO/DOX filaments  
a) b) 
c) 
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The possible formation of filament forms a mass, consisting of graphene oxide 
and doxorubicin.  
 
Fig. 4.31. SEM picture of composites based GO and DOX 
Spectrum 1 proves the Si surface, accordingly spectrum 2 proves that the 
filaments were based mainly from doxorubicin (according to the Brutto formula 
DOX- C27H29NO11), but some mismatches with amounts of oxygen (8.41 instead of 
15.51) and carbon (34.92 instead of 38.07) show that another material, graphene 
oxide, had an influence in this formation (Fig. 4.31, Table 4.4). 
Table 4.4. EDX analysis of composites based on GO and DOX  
Results in atomic% C N O Si S 
Spectrum 1 5.01 0.45 1.21 93.13 0.19 
Spectrum 2 34.92 1.41 8.41 55.27 0.01 
4.2.1.3 Conclusion 
It was found that advanced macromolecules using graphene-based material, 
graphene oxide and anticancer drug- doxorubicin could be formed. The obtained 
results validated the concept of using covalent linkage of the carboxyl group from 
GO with the amino group from doxorubicin. The GO/DOX mixture led to the 
reduction of the DOX concentration in drugs with the purpose of reducing the 
undesirable side-effects and could be used as a drug-drug delivery system for 
healing tumours and future theranostics.  
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4.2.2 Graphene oxide functionalisation with cationic mesa-tetra(4-pyridyl) 
porphine 
Cationic GO/TPyP hybrid structures have been synthesised by ionic self-
assembly. The different aggregated structure shape was obtained through 
electrostatic and π-π stacking interactions. The investigation revealed a three-
dimensional fibre structures formation under acid conditions and leaf-like structures 
of the GO/TPyP assemblies under alkaline conditions of the solution. This new 
synthesised macromolecule based on graphene shows a potential use for tissue 
engineering applications.  
4.2.2.1 UV-Vis characterisation of GO-TPyP aggregates  
As shown in Fig. 4.32, the ground state absorption spectrum of TPyP exhibited 
a very intense Soret band (Qmax - 419 nm) corresponding to the S2 transition, while 
the weaker Q bands between 500 and 600 were assigned to a pair of vibronic 
progressions corresponding to S1 transition (Khenfouch et al., 2014). After adding 
GO and changing the pH level to pH 5.4 the position, width and intensity of the 
absorption spectra of GO/TPyP solution were changed. The most obvious change 
occurred in the Soret band region of the absorption spectrum: the intensity of the 
original Soret band at 419 nm decreased gradually and a new Soret band appeared at 
442 nm. This red shift indicates that interactions took place between GO and TPyP. 
The results indicate that the functional groups on the surface and edge of graphene 
sheets played an important role in interactions between various molecules through 
supermolecular interactions such as π-π stacking, electrostatic interaction and 
hydrogen bonding (Fagadar-Cosma et al., 2009). The similar results have been 
demonstrated (Kaplan, Korin and Bettelheim, 2014) in the pH range 6-13. 
 
Fig. 4.32. Absorption spectra of TPyP and TPyP with GO in different pH levels  
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 Since TPyP is positively charged owing to the presence of pyridyl groups, the 
GO sheets have negative ζ-potentials in both deionised water and ionic salt 
solutions. The oxygen amount in the GO (hydroxyl (-OH), carboxyl groups (-
COOH), epoxy (C-O-C) groups) affects the surface charge and its dispersion in 
aqueous solutions. Although ζ-potential plays a key role in colloidal stability, it does 
not show the true particulate state in various environments. The GO dispersion 
showed an excellent colloidal stability in deionised water even after 24 h at room 
temperature. This is because of their high negative surface charge (electrostatic 
stabilisation). However, in the presence of TPyP, GO formed observable aggregates 
and came completely out of suspension after 1 hour incubation at room temperature. 
Hydrophobic and π-π interactions acted as the driving forces to promote GO self-
organisation process, which was highly enhanced by ionic self-assembly with 
oppositely charged TPyP. The influence of pH on GO/TPyP composites aggregation 
was also studied by optical microscopy in the pH range 1.5–9.1 (Fig. 4.33).  
   
 
Fig. 4.33. Aggregation of pH-depended GO/TPyP products formed during 10 min on the 
glass surface (optical microscopy images (125x) of the drop casted GO/TPyP or TPyP 
solution) 
After adding GO dispersion into TPyP solution, fluorescence quenching was 
also noticed with the increase in graphene concentration. The fluorescence 
quenching effect could be ascribed to the porphyrin/graphene interactions enlarging 
the conjugation of the porphyrin system, which is an efficient electron or energy 
transfer from the excited state of the cationic porphyrins to graphene and the 
occurrence of photo-induced electron transfer between the aromatic molecules and 
graphene. 
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4.2.2.2 SEM and AFM characterisation of GO/TPyP aggregates  
The investigation of a dried solution drop by SEM revealed the formation of 
the mixture of GO/TPyP disordered aggregates and nanofibre network. The size and 
density of the nanofibres vary depending on the time, concentration of TPyP, GO 
and pH of the solution. The formation rate of nanofibres is growing with the 
increase of GO concentration. Investigation of the pH influence on the formation of 
fibre like structures have shown that the fibre like structure formation process 
occurred in the acid solutions, and a low pH solution produces a high density fibre 
network. The high pH solution produces the complex, branched structures of 
GO/TPyP aggregates. The AFM measurements have shown that the size of 
nanofibres is growing in time and fibres from a tenth of a nm to hundreds of 
nanometres in diameter were produced over 2 hours (Fig. 4.34). 
 
Fig. 4.34. AFM image of GO/TPyP hybrid aggregates 
 The SEM of GO has shown a typical crumpled and wrinkled structure. The 
surface became rough and the rod-like structures appeared after the formation of 
GO/TPyP aggregates (Fig. 4.35, a). To investigate the profile of the fibres, the 
focused ion beam (FIB) was used to cut the fibres during the SEM measurement. 
The SEM images of the fibre cross-section demonstrate that the fibres are solid 
flattened structures with a width up to 900 nm and the height up to 500 nm (Fig. 
4.35, b and c).  
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Fig. 4.35. SEM images of GO/TPyP hybrid aggregates: a) network of GO/TPyP fibres, b) 
and c) FIB made cross section of the fibre 
EDX analysis was used to investigate the elemental composition of the 
nanofibres. The chemical element analysis on the fibres and the sheet-like 
aggregates outside a fibre area have shown that the fibre consist mainly of carbon 
(70.81%), nitrogen (17.58%) and oxygen. Smaller amounts of nitrogen (5.89%) with 
carbon and oxygen were detected near the nanofibres on the graphene oxide flakes 
(Table 4.5). This can be explained by the increased porphyrin role in the fibres 
formation. The nitrogen detected on the nanofibres indicates the presence of the 
TPyP and it confirms the suggested ionic mechanism of the hybrid aggregates 
formation.  
a) 
b) c) 
1 
2 
3 
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     Table 4.5. EDX analysis of composites based on GO and TPyP 
Results in atomic % C N O 
Spectrum 1 (on fibre) 70.81 17.58 11.61 
Spectrum 2 (near fibre, on aggregates) 76.56 7.24 16.2 
Spectrum 2 (on the GO flake) 79.53 5.89 14.58 
4.2.2.3 Raman spectroscopy characterisation of GO/TPyP aggregates 
The Raman spectra of nanoaggregates and nanofibres are shown in Fig. 4.36. 
The GO/TPyP nanoaggregate Raman spectra D band around 1,340 cm-1 and G band 
around 1,592 cm-1 are the characteristic of graphene oxide. The similar results have 
shown Raman spectra of the nanofibre, with 1,349 cm-1 and 1,596 cm-1 bands shift. 
The bands 993 cm-1, 1,428 cm-1, 1,446 cm-1 and 1,547 cm-1 corresponds to TPyP, 
indicating that TPyP has bound to graphene. The larger D/G bands intensity for 
nanofibre structure suggests that more graphitic domains are formed and the sp2 
cluster number is increased (Ferrari, Robertson, 2000). 
 
Fig. 4.36. Raman spectra of GO/TPyP nanofibre and nanoaggregate (λex- 532 nm) 
4.2.2.4 Current-voltage characteristics of the aggregates 
The dependence of the conductivity on the electric field and the GO thickness 
provides information on electric transport perpendicular to the sheets of GO/TPyP 
structures. The local current-voltage characteristics were measured by setting the 
AFM cantilever at different positions on the GO/TPyP sheets and nanofibres. 
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Current-voltage characteristics of GO/TPyP layers have shown current fluctuations, 
probably, because the current is sensitive to contact force. The experiments have 
shown that in the case of thin GO/TPyP sheets (Fig 4.37, a) conductivity is higher 
and fits the Poole-Frenkel model, and in the case of nanofibres, consisting of many 
GO layers and therefore a low electric field between a layers, the Schottky emission 
mechanism takes place (Fig 4.37, b). The conduction mechanism is ascribed to the 
Schottky emission mechanism (at low electric fields) or Poole-Frenkel emission 
mechanism (at high electric fields) (Chang, Lin, 2001). It was shown that the 
conductivity of synthesised nanofibres can be increased by GO sheets reduction.  
 
Fig 4.37. Current-voltage characteristic of GO/TPyP aggregates: a) GO sheets functionalised 
with TPyP molecules and b) synthesised GO/TPyP nanofibres 
4.2.2.5 Conclusions 
In summary, hybrid GO/TPyP nanofibre-type structures were synthesised. The 
characterisation of the obtained structures has shown the fibres can vary in diameter 
from tens to hundreds of nanometres and produce a network like structure. The UV-
Vis, EDX and Raman scattering spectra investigations confirm the formation of 
TPyP and GO hybrids.  
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4.3 Nanoparticles interaction with lipid membranes, as a model for graphene-
based materials interaction with bio-membranes   
4.3.1 Formation and characterisation of lipid membranes  
4.3.1.1 Formation of bilayer lipid membrane 
The formation of bilayer lipid membranes (BLMs) was performed according 
to the procedure described in 3.2.7. The formation of BLM was monitored and 
estimated using different techniques; optical microscopy, SAF and AFM. 
Monitoring lipid solutions in PBS buffer the formation of vesicles was noticed (Fig. 
4.38). It confirms that the formation of lipid membrane was preceded by the lipid 
vesicle fusion method.  
  
Fig. 4.38. Optical picture of lipid vesicles in PBS buffer 
Lipid monitoring by AFM and SAF was performed for one hour in the same 
place. During this time the whole formation from the first vesicles attached to the 
surface until the formation of a homogeneous membrane was recorded (Fig. 4.39).  
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Fig. 4.39. The formation of lipid membrane by a) SAF and b) AFM 
4.3.1.2 BLM characterisation with AFM and SAF 
Lipid membrane measurements were performed in a water environment to 
ensure the natural conditions for lipids. The roughness of the membrane 
significantly influences the capacity and optical parameters of BLM. Therefore, the 
study of these characteristics provides information on the bilayer structure (Hianik 
and Passechnik, 1995). The lipid membrane surface roughness is influenced by the 
vertical lipid motion. Stable rough membranes are less funnel-like and more 
structured (Schneider, 1996). Membrane surface roughness, homogeneity and lipid 
dynamics are used to determine the quality of a BLM. Therefore, AFM was used for 
lipid membrane roughness measurements. The characterisation of BLM was 
performed on a glass surface. The surface roughness was measured with AFM (Fig. 
4.40). The roughness of the glass surface, on which the lipid membrane was formed, 
as measured, was in the range ~5-8 nm. The AFM cross-section was used to 
estimate the roughness of the membrane. The roughness of lipid membrane was 
found to be ~ 2-4 nm. It was previously shown that stable membrane roughness 
could have a range of 0.5-5 nm (Schneider, 1996). Also, the fractal dimension of 
lipid membrane was measured - D-2.7. A fractal dimension is an index for 
characterising fractal patterns or sets by quantifying their complexity. A surface with 
fractal dimension of 2.7 fills the space orderly rather like a volume. 
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Fig. 4.40. a) 2D and b) 3D AFM images of lipid membrane surface. In the insert: a) cross 
section of lipid membrane surface, whereas in b) fractal dimension (D-2.7) of lipid 
membrane picture 
Images of fluorescently labelled lipid membranes were recorded with a 
custom-made scanning microscope allowing the detection of fluorescence and the 
supercritical angle fluorescence (SAF) images of an emitter simultaneously. The 
SAF channel detects only fluorophores in close proximity to the surface (∼100−200 
nm) and efficiently rejects the fluorescence from the bulk solution using parabolic 
lenses as the decisive optical element. All measurements were conducted by passing 
buffered solutions of NP’s over the lipid membrane through the flow cell at a 
constant pump rate of 250 μl/min (0.42 mm/s). 
 SAF measurements were used to estimate BLM deposition on the surface and 
homogeneity of BLM. FCS measurements were used (Fig. 4.41) to investigate the 
lipids diffusion in the membrane. The BLM investigation was performed with SAF 
microscopy combined with the FCS as a sensitive and efficient method to study the 
labelled lipids. As it is seen in SAF images, a homogeneous and non-damaged lipid 
membrane was formed.  
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Fig. 4.41. a) The correlation curve of BLM and the diffusion coefficient determined by 
fluorescence correlation spectroscopy (the solid grey line represents the fitting curve for the 
corresponding curve) b) 2D image of lipid membrane fluorescence 
Diffusion coefficient value (D) of a stable, non-damaged lipid membrane 
formed from DOPC: DOPS phospholipids should be in the range of 2-4 E-12 m2 s-1 
(Štefl, Kułakowska and Hof, 2009). The obtained diffusion coefficient of mixed 
bilayer LMs synthesised using DOPS:DOPC lipids are 2.5155 E-12 m2 s-1. 
4.3.1.3 BLM characterisation with Raman spectroscopy 
LM was formed on optically active surfaces based on Ag or Au nanostructured 
film deposited by chemical reduction using HF etched silicon (the preparation of 
SERS substrates is described in section 3.2.9).  
The scheme of lipid membrane (LM) formation on different types of SERS 
surfaces (unmodified Au SERS, modified Au SERS with 1-dodecanethiol and 
unmodified Ag SERS) is presented in Fig. 4.42   
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Fig. 4.42. The scheme of lipid membrane formation on different types of SERS surfaces: and 
unmodified Ag SERS, unmodified Au SERS and modified Au SERS with 1-dodecanethiol 
layer, respectively 
A mixed DOPC:DOPS lipid membrane deposited on Au and Ag SERS 
substrates in PBS solution was investigated using Raman spectroscopy to investigate 
the interaction of LMs with surfaces. No Raman peaks were obtained in the cases 
when LMs are formed on blank silicon (data not shown) and on the unmodified Au 
SERS substrate (Fig. 4.43, line 3). The absence of Raman peaks of the LMs 
deposited on Si can be explained by the low sensitivity of Raman spectroscopy at 
the nanoscale. The same phenomenon is observed in Raman spectra of LMs 
deposited on the Au SERS substrate. However, in this case the LM was probably 
unable to compose on the surface because of the poor wetting of the surface (Cha, 
Guo and Zhu, 2006). In order to deposit LM on gold surfaces the intermediate 
molecules should be used to create self-assembled monolayers (SAMs) 
(McGillivray et al., 2007). Due to the selected SAMs, a bilayer LM or monolayer 
LM can be obtained (Marques et al., 2014).  
The lipid membrane formed onto modified Au SERS (Fig. 4.43, 4 line) shows 
peaks of high intensity in both 2,840-3,040 cm-1 and fingerprint (<1,800 cm−1) 
regions, such as 997 cm-1 (O-P-O), 1,307 cm-1 (CH2 twist), 1,445 cm-1 (CH2 bend), 
1,608 cm-1, 1,672 cm-1 (cis C=C stretching vibrations) (Gunstone, Harwood and 
Dijkstra, 2007). The Au SERS enhancement of the methyl deformation (lipid tail 
group, 1,307 cm-1) and no peak aligned with the carbonyl group stretch (lipid head 
group, C=O, around 1,700 cm-1) could be explained by the tail group being closer to 
the Au SERS surface than the head group. The Raman spectra of the used binding 
layer (1-dodecanethiol) on the silicon surface are presented for comparison (Fig. 
4.43, 2 line). Finally, the presence of the phospholipid monolayers and bilayers can 
be observed in the 2,750-3,050 cm−1 regions. In particular, the presence of an intense 
band at 2,960 cm−1 (assigned to the asymmetrical stretching vibration of the methyl 
groups) is intense in the case of phospholipid bilayers (Saint-Pierre Chazalet et al., 
1994).  
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Fig. 4.43. Raman spectra of LMs on different SERS substrates in PBS solution (λex- 532 nm) 
However, the bilayer LM bands in the Ag SERS spectrum are clearly 
enhanced and, compared to the spectrum of the LMs on Au SERS substrate and 
DOPS:DOPC bulk measurements, changed in shape. In general, Ag nanoparticles 
could interact with cell membranes by first binding at the membrane-water interface. 
Interfacial interactions are based on surface structure and membrane lipid 
composition. A nanoparticle from the surface can interact with the membrane and 
disrupt the lipid organisation and membrane structure (Nel et al., 2009). Considering 
that the interaction of LM with a nanostructured silver surface can occur through 
coordination complexes formed between nanoparticles and active functional head 
groups such as phosphate PO3– or COO-, we hypothesised that a bilayer LM with 
SERS substrate interacts through both groups. The COO- bond region in SERS 
spectra, suggesting the possible interaction of lipid molecules with Ag, is located at 
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1,312-1,424 cm−1. Raman scattering of PO3– have several typical peaks at 1,138 cm-
1, 1,001 cm-1 and 710 cm-1 (Novita, Boolchand, 2007) (Fig. 4.43, 5 line). In this case, 
lipid molecules probably interact with Ag NPs through coordination complexes. The 
lipid membrane formed onto modified Ag SERS also shows high intensity of peaks 
in both: 2,840-3,040 cm-1 and fingerprint (<1,800 cm−1) regions. It is important to 
note that the shifted peaks can be the result of lipid interactions with the 
nanostructured silver surface. The assignment of Raman bands for phospholipids is 
shown in Table 4.6.  
 Table 4.6. Assignment of Raman bands of phospholipids (Gunstone, 2007) 
Raman band position, cm-1 Assignment 
800-920 C-C stretching 
945-970 C=C in-plane bending 
1,060-1,136 C-C stretching 
1,250-1,280 =C-H bending 
1,295-1,305 C-H twisting deformations 
1,400-1,500 C-H scissoring deformations 
1,640-1,680 C=C stretching 
1,730-1,750 C=O stretching 
2,700-3,015 C-H stretching 
 
As it is seen in Fig. 4.43 the peaks of LM obtained on the Ag SERS substrate 
are of higher intensity in comparison with Au SERS. The difference of spectra 
recorded on various SERS substrates is thought to be due to the bilayer LM having 
double the thickness of the monolayer and a different sample preparation method 
(McClements, 2014). During the preparation procedure, the lipids are deposited 
directly on the Ag SERS surface. Therefore, some parts of the lipids can interact 
with Ag NPs and be selectively enhanced. According to that, the Au SERS substrate 
was modified with a binding layer of 1-dodecanethiol, and the lipids had no direct 
contact with Au NPs. For this reason, the intensity of the peaks was found to be 
significantly lower in comparison with Ag SERS. 
4.3.2 The interaction of nanoparticles with bilayer lipid membranes 
Nanoparticles (NP) are broadly exploited in biomedical sciences in order to 
develop various methods of targeted drug delivery, novel biosensors and new 
therapeutic pathways. However, relatively little is known in the negotiation of NPs 
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with complex biological environments. NP interactions with cell membranes can 
damage the cell membrane and cause toxicity; therefore, examining interactions 
between NPs and cell membranes is crucial to understanding NP toxicity 
mechanisms and the development of safe and non-toxic NP-based commercial and 
therapeutic applications. To gain a physical understanding of NP-membrane 
interactions, a simplified system built of well-defined synthetic lipid bilayers and NP 
was used. The interaction of nanoparticles with bilayer lipid membranes can lead to 
structural modifications of the BLM and affect the structure and dynamic of lipids. 
4.3.2.1 BLM interactions with GO nanoparticles 
In this section the interaction of the lipid membrane with GO was analysed 
using SAF spectroscopy, confocal microscopy and Raman spectroscopy.  
Initially, the GO flakes were measured on SAF without the lipid membrane. It 
was noticed that GO is a fluorescent, non-dynamic material (see Fig. 4.44) and it 
could be easily detected on the membrane because of this characteristic. GO 
fluorescence is more noticeable on the undercritical angle fluorescence (UAF) 
channel, so this is also a good way to separate BLM fluorescence form GO 
fluorescence. 
 
Fig. 4.44. a) The correlation curves of GO and the diffusion coefficient determined by FCS 
b) SAF 2D image of GO flake fluorescence c) UAF 2D image of GO flake fluorescence  
To confirm NP’s aggregate attachment to the BLM surface, FCS 
measurements were used indicating the impact of NP’s on the lipid diffusion in the 
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BLM. The lipid membrane diffusion noticeably decreased in the place where GO 
flakes are attached to the surface (D is in the range 5-7 E-13 m2 s-1). 
As shown in Fig. 4.45, the fluorescence intensities of BLM after 16 hours of 
exposure to a suspension of GO were recorded. The increased fluorescence intensity 
of the membrane with GO (0.05 g/ml) reflects on the possible GO flakes deposition 
on BLM. From Fig. 4.45 it is seen that diffusion curves and coefficients (D, from 
FCS measurements) indicating the difference in the presence (blue line, when 
measured near visible GO flake and red line, when measured directly on the GO 
flake) and the absence (D- 2.57 E-12 m2 s-1, typical diffusion coefficient for pure 
lipid membrane; black line) of GO. The dotted lines represent the fitting curves for 
corresponding FCS curves. The significant reduction of D can be explained as a 
result of lipid-GO flakes binding. 
 
Fig. 4.45. a) The correlation curves of BLM and BLM with GO in different places and the 
diffusion coefficients determined by fluorescence correlation spectroscopy b) 2D image of 
lipid membrane and GO nanoparticle fluorescence  
The possible model of GO flake-lipid membrane interaction is proposed in 
Fig. 4.46. It is in line with other studies, where it is explained that the GO flake is 
cutting the lipid membrane and part of the graphene oxide flake could be not visible 
in UAF or confocal pictures, but it could be detected by Raman spectroscopy (Fig. 
4.46) and after measuring lipid diffusion changes near the visible GO flake (Fig. 
4.45, red line).  
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Fig. 4.46. The proposed model of how graphene oxide gets into the membrane 
4.3.2.2 BLM interaction with other nanoparticles: TiO2 and ZnO  
TiO2 and ZnO nanoparticles were chosen because of their wide applications 
and usage in the paper, ink, medicine, food products, cosmetics, toothpaste and skin 
care product industries, among others. Therefore, a better understanding of the 
interactions between NP and the lipid membrane may help to clarify the potential 
risk of NPs.  
AFM and TEM were used to determine the size of NPs. The grain analysis 
function was used and then the distribution of NP size was built. It gives the size of 
ZnO as 20.2 nm (standard deviation (SD)-9.47 nm) and TiO2 gave the size value of 
35.3 nm (SD-9.20 nm) (Fig. 4.47). Also, zeta potential measurements were 
performed. The magnitude of the zeta potential indicates the degree of electrostatic 
repulsion between adjacent, similarly charged particles in dispersion. ZnO zeta 
potential variation with pH 7-8.5, dispersions are stable and positively charged (with 
pH 7.4 ~ +3 mV). It is known that low zeta potentials tend ZnO suspension to 
coagulate or flocculate. In TiO2 zeta potential variation with pH 5-9, dispersions are 
stable and the surface is positive (with pH 7.4 ~33 mV). In this case, a high zeta 
potential will confer TiO2 stability, i.e., the suspension resists aggregation.  
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Fig. 4.47. AFM images of a) ZnO and b) TiO2 nanoparticles, respectively 
The BLM contained one part of negatively charged phospholipids (DOPS) and 
the other part of neutral phospholipids (DOPC) because the chosen ratio is similar to 
the composition of the inner leaflet of neuronal membranes, which is typically 
enriched with negatively charged phospholipids in the range of 15-30 mol%. 
Generally, the interaction of nanoparticles with hydrophilic interfaces requires 
negative surface charges implying a strong contribution of electrostatic forces during 
the adsorption event. As shown in Fig. 4.48, the fluorescence intensities of BLM 
after 16 hours of exposure to a suspension of ZnO or TiO2 were recorded. The 
reduced fluorescence intensity of the membrane with ZnO (2.5 mg/ml) reflects on 
the possible ZnO aggregates deposition on BLM. The measured zeta potential of 
ZnO suspension shows the high probability of aggregates formation, which could 
quench the fluorescence intensity. The possible explanation of why we obtained 
differences with different NPs is because the various (from 3 to 33 mV) zeta 
potentials lead to stability of suspension (TiO2 case) or big aggregate attraction to 
the lipid bilayer (ZnO case).  
 
Fig. 4.48. SAF images of the scanned areas acquired after 16 hours of exposure to a 
suspension of ZnO or TiO2 with different concentrations on the lipid membrane bilayer 
demonstrating ZnO and TiO2 interaction with the lipid membrane 
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To confirm NP’s aggregate attachment to the BLM surface, FCS 
measurements were performed (Fig. 4.49) indicating the impact of NPs on the lipids 
diffusion in the supported lipid bilayer at different concentrations. To investigate the 
ZnO and TiO2 NP’s interaction and aggregation with supported lipid bilayers at 
different concentrations we employed SAF microscopy combined with the 
fluorescent correlation spectroscopy (FCS) as a sensitive and efficient method to 
study the interaction of nanoparticles with supported lipid bilayers under continuous 
and constant flow conditions.  
The influence of the addition of the ZnO or TiO2 NPs to the lipids suspension 
and the NP’s effect on the supported lipid membranes was studied by analysing the 
FCS measurements of the labelled DOPE lipids contained inside membranes before 
and after the addition of nanoparticles. Fig. 4.49 illustrates three independent 
measurements of the diffusion coefficient without the addition of nanoparticles and 
after the addition 1 mg/ml and 2.5 mg/ml ZnO or TiO2 concentration, respectively. 
Both NPs show slight variations (diffusion coefficient (D) is in the range of 2-3 E-12 
m2 s-1) in the diffusion coefficient values, with no defined trend. FCS measurements 
reveal that the significant reduction of D (D- 4.91 E-13 m2 s-1) occurs only after the 
addition of 2.5 mg/ml ZnO; other samples remained quite stable for a longer period 
of time. The effect could be due to the unstable suspension caused aggregations 
connections to the BLM surface.  
 
Fig. 4.49. Fluorescence intensities of lipid membrane with and without a) ZnO or with b) 
TiO2. Diffusion curves (from FCS measurements) indicating the difference in the presence 
and absence of 2.5 mg/ml ZnO (the solid black lines represent the fitting curves for 
corresponding FCS curves) 
The lipid-ZnO aggregates binding effect is enlarged with the increasing ZnO 
concentration. The higher ZnO concentration leads to the enhancement of the D 
reduction. This is in line with other studies, which reported that a noticeable 
influence over lipid membranes is observed at higher concentrations of cholesterol, 
proteins or other nanoparticles (Kahya et al., 2004; Kahya and Schwille, 2006; 
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Sahoo and Schwille, 2013; Bockmann et al., 2003; Machan and Hof, 2010). This 
effect is explained by the reduction of the free area because of tighter lipid packing. 
The scanned images of SAF reveal that the bilayer integrity is not altered for 16 
hours after the addition of nanoparticles. Thus, the higher concentration of ZnO 
fluorescence intensity is significantly lower from the others presented in Fig. 4.48. 
The possible explanation is that the ZnO zeta potential (with pH 7.4 ~ +3 mV) could 
affect the lipid’s mobility due to the unstable suspension caused aggregations 
connections to the BLM surface. As opposed to TiO2 zeta potential variation (with 
pH 7.4 ~33 mV) that shows stable suspension. Experimental results suggest that the 
nanoparticle–membrane interaction depends on the NP charge as well as the zeta 
potential. Cationic nanoparticles are known to penetrate through the cell membrane. 
It seems evident that the binding of TiO2- with the membrane takes place through 
relatively weak contacts since NP did not immerse deeply in the membrane, but 
floated on top of the bilayer surface, enabling diffusion of the membrane, with no 
adsorption to the membrane. This is in line with other studies, where it was reported 
that a noticeable and statistically significant (p<0,001) influence on phospholipid 
vesicles were observed after incubation of ZnO (but not TiO2) nanoparticles 
(Šimundic et al., 2013). 
This is known that agglomerates larger than 0.2 μm were found attached to the 
membrane (Rothen-Rutishauser et al., 2006), whereas smaller aggregates and single 
particles could probably cross the membrane through pores or ion channels (Porter 
et al., 2006). In addition, aggregates adhere to surfaces and may therefore cause 
effects without even entering cells. 
The effects of NPs on BLM are important for understanding the potential 
effects of NPs on biological membranes. Limited biological relevance of the results 
of experiments with BLM does not mean that these results have no value for 
understanding the effects on biological membranes. It is indicated that ZnO (but not 
TiO2) can cause the changes of the membrane characteristics if it can get close to the 
phospholipid bilayer.  
4.3.2.3 Conclusions 
The impact of NPs, being essential constituents of drugs and cosmetics, on the 
dynamics of lipid molecules in bilayer membranes were investigated. Using 
electrostatically attached NPs of positive charge on negatively charged supported 
model membranes, we demonstrated that the diffusion mobility of lipids within the 
GO and ZnO membrane slowed down significantly, depending on concentration and 
characteristics of NPs. The weak interaction was found between a stable dispersion 
of TiO2 and lipid bilayers. As an explanation, we suggest a mechanism of strong 
interaction between nanoparticles and the negatively charged lipids, thus forming 
tight nanoparticle-lipid complexes. The finding that diffusion of lipid molecules 
within the membrane significantly depends on interaction with NP represents a new 
step in understanding the interactions between NP and cells by demonstrating the 
non-destructive nature of the NP and lipid bilayer interaction and showing the 
importance of NP surface properties. 
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4.4 The introduction into the living cell and the toxicity of graphene oxide in 
different cell lines  
The evaluation of the cyto- and bio-compatibility is critical steps in the 
development of graphene oxide as a new promising material for in vivo biomedical 
applications. In this study, we report the impact of GO, with and without the 
addition of bovine serum albumin, on healthy (Chinese hamster ovary) and cancer 
(mouse hepatoma MH-22A) cell viability and the estimation of the intracellular 
distribution of GO inside the cells in vitro.  
4.4.1 Influence of GO on mouse hepatoma MH-22A and CHO cell viability 
The influence of GO on CHO and MH-22A cell viability was estimated using 
three concentrations of GO and the same concentrations of GO coated with BSA. 
The results of cell viability are presented in Fig. 4.50. Statistical analysis was 
performed by Student’s t-test (*p<0.05, **p<0.01, ***p<0.005). All data of GO and 
GO-BSA treatment are statistically significantly different from the control 
(p<0.005); between 12.5 µg/ml GO and 50.0 µg/ml GO - p<0.01 (in the case of 
CHO cells) and p<0.05 (in the case of MH-22A cells); between 12.5 µg/ml GO-BSA 
and 50.0 µg/ml GO-BSA - p<0.005 (in the case of CHO cells) and p<0.05 (in the 
case of MH-22A cells); 12.5 µg/ml GO and 12.5 µg/ml GO–BSA, p<0.05 (in the 
case of both cells lines); 25.0 µg/ml GO and 25.0 µg/ml GO –BSA, p<0.05 (in the 
case of both cells lines) and 50.0 µg/ml GO and 50.0 µg/ml GO–BSA, p<0.005 (in 
the case of MH-22A cells), p<0.01 (in the case of CHO cells). Also, a statistically 
significant difference has been established between CHO and MH-22A cells in the 
cases of the treatment with 12.5, 25.0 and 50.0 µg/ml GO, p<0.05. 
 
Fig. 4.50. Viability of CHO and mouse hepatoma MH-22A cells after the treatment with 
BSA, GO and GO-BSA at different concentrations of GO (the data were expressed as mean 
± standard error (SE) from three independent experiments)  
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Data have shown that the viability of the cells after treatment only with BSA 
was indistinguishable from that of the control. The viability of MH-22A cells 
decreased with increasing concentrations of GO (12.5-50.0 μg/ml) from 22% to 3%, 
the viability of cells after treatment with GO (12.5-50.0 μg/ml)-BSA (10%) 
decreased from 47% to 26%. Obtained results demonstrate that the viability of MH-
22A cells was higher in the case of GO-BSA use. The same tendency was observed 
with CHO cells: the viability of the cells decreases with increasing concentrations of 
GO from 44% to 11%, in the case of the use of GO-BSA - from 59% to 28%. The 
impact of GO on the decrease of cell viability was stronger in the case of MH-22A 
cells (Fig. 4.50).  
On the other hand, the results suggest that BSA binds to the surface of GO to 
form a coating known as a “protein corona”, which affects the cytotoxic action of 
GO and the level of GO cytotoxicity. It has already been reported that roughly one 
monolayer of BSA is necessary to completely cover the surface of Al2O3 particles 
and BSA starts forming dimers at the surface with increasing protein concentration 
through protein/protein interactions (Rezwan et al., 2004). It was established (Zhu et 
al., 2009) that serum proteins reduce the cellular uptake of multi-walled carbon 
nanoparticles and interpreted that this could happen because of decreased 
hydrophobicity of nanoparticles which occurred due to the binding with serum 
proteins. This finding suggests that in our study, BSA could reduce the cellular 
uptake of GO to the cells as well. 
Also, the influence of functionalised GO with DOX on MH-22A cell viability 
was estimated using lower concentrations of GO - 6.25 μg/ml and the same 
concentrations of functionalised GO with DOX without heating, after heating and 
coated with BSA. There are few commercial doxorubicin drug forms in the market, 
such as injection solution, ADRIAMYCIN or lipid complex, DOXIL. The 
concentration of both mentioned drugs is 2 mg/ml. To prevent the symptoms of 
overdose (seizures, unexplained bleeding) and side-effects (nausea, vomiting, 
diarrhoea and loss of appetite, a reddish colour to urine, tears and sweat and 
temporary hair loss, etc.) the concentration of DOX for experiments with hepatoma 
cells was greatly reduced to 0.05 μg/ml. Results of MH-22A cell viability are 
presented in Fig. 4.51. The usage of functionalised with and without heating GO 
with cancer drug- doxorubicin even at very low concentrations of DOX (0.05 μg/ml) 
showed that the viability of hepatoma cells was approx. 20 percent lower than using 
DOX separately- from 79% to 62% and 57%, respectively. The results demonstrate 
that viability of hepatoma cells was higher in the case of GO/DOX-BSA use. 
Statistical analysis was performed by Student’s t-test (*p<0.05, **p<0.01, 
***p<0.005). All data of GO and GO-DOX, GO-DOX (after heating), GO-DOX-
BSA treatment are statistically significantly different from the control (p<0.05); 
between DOX and GO-DOX, GO-DOX (after heating), GO-DOX-BSA - p<0.005. 
Wu et al. (2014) investigated cytotoxicity of graphene oxide and graphene oxide 
loaded with doxorubicin (50 mg/l and 2 mg/l, respectively) on human multiple 
myeloma cells and found GO/DOX significantly inhibited cell proliferation as 
compared to pure DOX (p<0.01). F Yang et al. (2008) also performed high-
efficiency loading and controlled release of doxorubicin on graphene oxide using 
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concentrations of DOX 0.47 mg/ml on GO. The loading and release of DOX on GO 
showed strong pH dependence. Though, there are no publications which investigated 
the cytotoxicity of the mixture of GO/DOX in such a low concentration on 
hepatoma cells. 
 
Fig. 4.51. Viability of mouse hepatoma MH-22A cells after the treatment with GO, 
GO+DOX, GO/DOX and GO/DOX + BSA (the data were expressed as mean ± standard 
error (SE) from three independent experiments)  
The interaction between GO and DOX without heating may be due to the 
hydrogen-bonding, π-π stacking and with heating due to the covalent bond between 
them (Yang et al., 2008). This could be the answer why GO/DOX complex affects 
the viability of hepatoma cells more (~5%) than just mixed GO+DOX. However, the 
observed difference is not statistically significant. 
It is known that the dynamics of cell growth, size and shape of the colony 
depend on the proliferation rate and metabolism of the cell (Huergo et al., 2012). 
Therefore, because GO has an influence on cell viability, it has to have an impact on 
the cell colony growth dynamics. In our work, we used the cell colony size 
differences to estimate the influence of GO on CHO and MH-22A cells. Colonies 
treated with GO and GO-BSA were smaller in comparison to the control. Bigger 
colonies possess considerably larger cell population size and a higher proportion of 
actively proliferating cells (Kitamura et al., 1986). The test colonies size decreased 
after the treatment with 12.5 µg/ml of GO. Optical micrograph of the colonies is 
shown in Fig. 4.52. The decrease of the colonies sizes after the treatment with GO 
and GO-BSA can be explained by decreased cell division and growth rate. This is in 
agreement with the results of other authors who supposed that cell cycle and growth 
rate can be perturbed after treatment with GO (Yuan et al., 2012). 
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Fig. 4.52. Optical micrograph of the colonies of a) CHO control cells, b) mouse hepatoma 
MH-22A control cells, c) CHO cells after the treatment with 12.5 µg/ml of GO, d) mouse 
hepatoma MH-22A cells after the treatment with 12.5 µg/ml of GO 
It is known that cells and multicellular structures can mechanically align and 
concentrate fibres in their extracellular matrix environment (ECM) and can sense 
and respond to mechanical or other cues by differentiating, branching, or 
disorganising. The ECM confers mechanical integrity with the tissue and provides 
chemical, anatomical and mechanical signals to cells, influencing differentiation, 
development and pathogenesis (Rauzi et al., 2009). Therefore, the single cell and 
colony morphology changes can be a cellular response to nanoparticles. To validate 
this hypothesis, we used the AFM investigation of control cells and cells after GO 
treatment. AFM is an established characterisation technique used for topographic 
imaging of different samples, including the biological cells. The ability to obtain 
topography images of cells allows for detailed cell morphology and roughness 
investigation (Franz et al., 2008; Andolfi et al., 2014; Ban et al., 2010; Oliveira et 
al., 2011; Toccafondi et al., 2014; Meincken, 2007) and their changes after the cell 
membrane interaction with nanoparticles (Lee et al., 2012). The studies have shown 
that surface roughness upon cellular incubation with nanoparticles changes 
depending on the time after incubation (Tapia-Tapia et al., 2009), this could be due 
to the restructuring of the membrane during the initial phase of endocytosis or this 
could also be a result of flattening of the cells or adaptation of the membrane in 
response to nanoparticle encounters (Hoskins et al. 2012). 
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Fig. 4.53. AFM images and e) the roughness average  (Sa) of a) CHO control cells, b) CHO 
cells after the treatment with 12.5 µg/ml of GO, c) mouse hepatoma MH-22A control cells, 
d) mouse hepatoma MH-22A cells after the treatment with 12.5 µg/ml of GO 
AFM images of the CHO and MH-22A control cells (Fig. 4.53 a, c 
respectively) and cells after the treatment with 12.5 µg/ml of GO for 24 hours (Fig. 
4.53 b, d respectively) were taken. The data clearly show that the structure of MH-
22A cells after exposure with GO was altered substantially, part of the cells (at the 
central part of the image) lost plasma membrane integrity. The average roughness of 
the cell surface in different areas was estimated by AFM (Fig. 4.53 e). The data of 
roughness average were expressed as a mean ± standard error (SE) from three 
independent experiments. A statistically significant difference has been revealed 
between CHO and MH-22A cells after the treatment with 12.5 µg/ml of GO, 
p<0.005. Also, data of GO treatment are statistically significantly different from the 
control, p<0.005 (in the case of MH-22A cells). The average roughness of control 
and treated CHO cells were similar and in the range of 16 ± 3 nm, while of the MH-
22A control cells were 14 ± 2 nm and treated MH-22A cells 7 ± 2 nm. The 
significant changes of the average roughness of the MH-22A cells after the 
treatment with GO confirms the impact of GO on cells membrane and probably 
internal structures and interconnections between the cells. MH-22A single cells as 
well as the cell colony network changed its mechanical structure after treatment 
(Fig. 4.53 d). The disorganisation of the single cell connections is clearly seen in the 
case of GO treatment of the MH-22A cells. This disorganisation of interconnections 
between cells and changes in the cell membrane structure, seen as morphology and 
surface roughness changes, demonstrates a strong GO influence on the biochemistry 
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of MH-22A cells and probably directly related with low viability of MH-22A cells 
after GO treatment. 
4.4.2 Distribution of GO in mouse hepatoma MH-22A and CHO cells  
Nanoparticle uptake and distribution inside a cell are still not well understood 
phenomena. In the case of GO, because of its high Raman activity, the Raman 
mapping (imaging) of GO is a promising technology, allowing it to work with cells 
in their native environment. In order to understand why GO was more cytotoxic to 
MH-22A cells as compared to CHO cells (Fig. 4.50), and functionalised GO with 
DOX and the effect of BSA (Fig. 4.51). Raman imaging was performed for an 
estimation of distribution of the GO in the studied cells (Fig. 4.54). 
 
Fig. 4.54. Raman scattering images of a) GO distribution in CHO cell, b) GO distribution in 
mouse hepatoma MH-22A cell c) GO/DOX distribution in mouse hepatoma MH-22A cell d) 
GO/DOX distribution with BSA mouse hepatoma MH-22A. Intensity maps of the ‘G’ band 
of GO nanoparticles: the white colour represents the area where Raman spectra of 
nanoparticles were not observed, the blue - red - violet colour areas represent determined 
spectra of GO with increasing intensity, respectively (the optical scanning confocal image of 
the investigated cells as a grey background overlapped the Raman images of GO 
distribution) 
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To monitor the distribution of GO across the cell, we measured the series of 
Raman spectra across the cell in the Z axis, perpendicular to the cell surface, starting 
from the outside of the cell (Fig. 4.55). It was found that at the level of the cell 
membrane the Raman spectrum of GO was not observed. Positioning the laser beam 
with the step of 0.3 µm down into the cell the intensity of GO Raman spectra was 
increasing and reached maximum intensity close to the bottom membrane of the cell. 
These results demonstrate that GO are localised inside the cells. In comparison of 
GO/DOX and GO/DOX+BSA groups, after Raman spectra across the cell in the Z 
axis measurement the lower intensity (~24%) of GO peaks was detected inside the 
cells. This effect could be explained that lower Raman signals could be obtained due 
to protein corona which surrounds the GO nanoparticles and protects them from the 
negative effect to cells viability.   
 
Fig. 4.55. Raman spectra recorded consistently across Z axis (the distance between each 
Raman spectra ∆z=0.3 µm) of a) CHO cell, b) mouse hepatoma MH-22A cell after 
interaction with GO c) mouse hepatoma MH-22A cell after interaction with GO/DOX. d) 
GO/DOX distribution with BSA mouse hepatoma MH-22A (λex- 532 nm) 
Results of Raman imaging of the cells, treated with the same concentration of 
GO, have shown that approximately 60% of the MH-22A cells occupied surface area 
is filled with GO, while in the case of CHO, approx. 20% (Fig. 4.54). GO is 
concentrated in several spots, preferably in the periphery of cell cytoplasmic area. 
The Raman imaging of functionalised GO with DOX reveals more intensive areas, 
this means that a higher amount of functionalised GO was introduced inside the 
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cells. Additional BSA amounts “protect” the cells from GO/DOX influence. These 
findings suggest a more detailed explanation of our cell viability results: the viability 
of MH-22A cells is decreased more in comparison with CHO cell viability because 
of larger volumes of GO accumulated in these cells. A higher accumulation of GO 
led to a disordering of cell interconnections and changes in membrane structure 
(confirmed by AFM imaging) and, as a consequence, to a lower rate of cells 
proliferation and growth. It is difficult to explain why more GO is accumulated in 
MH-22A cells. Differences between the plasma membrane composition of healthy 
and cancer cells could be one of the reasons (Gao et al., 2013). It has already been 
reported that different uptake pathways are observed for gold nanoparticles in 
healthy (MCF-10A) and cancer (HeLa) cells (Saha et al., 2013). The results of 
Raman imaging are in agreement with the results of other authors who investigated 
the cellular internalisation of GO loaded with Au nanoparticles using surface-
enhanced Raman scattering (SERS) spectroscopy. It was shown that GO was 
distributed inhomogeneously inside the Ca Ski cells (Huang et al., 2012). Authors 
(Liu et al., 2012) using Raman imaging at the different parts of the Hela 229 cells 
observed the different Raman intensities and proposed that the internalisation of GO 
in the Hela 229 cells occurs by the endocytosis pathway. 
4.4.3 Conclusions 
The cytotoxicity of GO was investigated with the two cell lines using colony-
forming assay. Research results have shown that the viability of the cells decreased 
with an increased concentration of GO (in the case of CHO cells from 44% to 11%, 
MH-22A cells, from 22% to 3%). It was found that 50 μg/ml of GO was the critical 
concentration (almost all cells were killed). The usage of functionalised GO with 
cancer drug, doxorubicin, even at very low concentrations showed a statistically 
significant result, the viability of hepatoma cells was approx. 20 percent lower than 
using DOX separately. When nanoparticles were used with the addition of 10% 
BSA the viability of cells was higher because of protein corona formation on the 
nanoparticles. The results of cell colony assessment by optical imaging confirmed 
the results of the cell viability test. Raman imaging results of GO intracellular 
distribution in the cells suggest that the viability of MH-22A cells was decreased 
because a larger volume of GO was accumulated in these cells in comparison with 
CHO cells or with cells where GO was not functionalised. A strong GO influence on 
cell membrane morphology and interconnections network growth between cells was 
confirmed by AFM imaging. The AFM data clearly shows that GO has a different 
influence on the separate cells lines.  
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5 GENERAL CONCLUSIONS 
 
1. The new hybrid nanostructures were synthesised by functionalisation of: 
graphene with iron and metal-free meso-tetra (4-sulfonatophenyl) porphines 
(FeTPPS and TPPS), graphene oxide with hematoporphyrin (HP), graphene oxide 
with meso-tetra (4-pyridyl) porphine (TPyP) and graphene oxide with anticancer 
drug- doxorubicin (DOX). The investigation and evaluation of synthesised 
nanostructures has been performed by Raman spectroscopy and imaging, Atomic 
force microscopy, Scanning electron microscopy, Fourier transform infrared 
spectroscopy, Supercritical angle fluorescence and UV-Vis spectroscopies.  
2. The graphene functionalisation with iron and metal-free meso-tetra (4-
sulfonatophenyl) porphines was carried out by a strong non-covalent interaction 
through pyrrole and desulphonated phenyl rings of closely located planar TPPS 
molecules on the graphene surface. The protonation of porphyrin macrocycle or the 
existence of a central metal atom for the TPPS family plays an important role in the 
molecular conformation and orientation when interacting with a single-layer 
graphene. Interaction between diprotonated TPPS and graphene causes the 
deprotonation process of porphyrin macrocycle, during which a shift in the direction 
of shorter wavelength for the G and 2D peaks was noticed, this could be caused by 
the transfer of electron charge from the TPPS molecule to graphene and it 
chemically strengthens Raman signals. During the interaction between deprotonated 
TPPS and graphene atomic changes take place, because of which new Raman bands 
appear. The presence of an iron atom in the porphyrin macrocycle provides stability 
for the FeTPPS molecule during the interaction and weakens the Raman signals, 
despite the effect of charge transfer. 
3. The functionalisation of graphene oxide with hematoporphyrin leads to the 
nanocomposite of a layered structure composed of hematoporphyrin oligomers 
adsorbed on the surface of graphene oxide in a monolayer through covalent, 
electrostatic and p-stacking interactions. Nanocomposites stable in aqueous media at 
neutral pH hematoporphyrin/graphene oxide were obtained as a result of 
esterification reaction catalysed by sulfuric acid.  
4. A synthesis of graphene oxide with cationic meso-tetra (4-pyridyl) porphine 
due to ionic self-assembly leads that a hybrid graphene oxide/TPyP nanofibre-type 
structures was synthesised. The investigation revealed a three-dimensional fibre 
structure formation under the acid conditions and leaf-like structures of the graphene 
oxide/TPyP assemblies under the alkaline conditions of the solution. The 
characterisation of obtained structures has shown the fibres can vary in diameter 
from tens to hundreds of nanometres and produce a network-like structure. Due this 
formation of the nanofibres the proposed cationic porphyrin-graphene oxide 
synthesis method is not suitable for drug delivery. Indeed, these network-like 
structures can be used in tissue engineering purposes.  
5. The functionalisation of graphene oxide with the anticancer drug 
doxorubicin leads to the nano- and microcomposites composed of doxorubicin 
adsorbed on the surface of graphene oxide through covalent and non-covalent 
interactions, such as electrostatic and π-π stacking interactions. The formation of 
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such graphene oxide/doxorubicin hybrid opens the way to create drug-drug delivery 
systems for treating cancer and theranostics. 
6. Lipid membranes, as a model for nanoparticle interactions with bio-
membranes, have been formed of neutral 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) on negatively charged 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) 
phospholipids. The diffusion mobility and structural integrity of lipids was 
investigated by supercritical angle fluorescence spectroscopy and fluorescence 
correlation spectroscopy; after the interaction of lipid membrane with the graphene 
oxide and ZnO nanoparticle membrane slowed down significantly (D- 5-7 E-13 m2 
s-1), also the weak interaction (D- 4.91 E-12 m2 s-1) was found between a stable 
dispersion of TiO2 nanoparticles and lipid bilayer membranes.  
7. It was approved that the transfer of graphene oxide into the cell proceeds 
through penetration into the membrane. The cytotoxicity of graphene oxide was 
investigated with the two cell lines using a colony-forming assay. Research results 
have shown that the viability of the cells decreased with increasing concentrations of 
graphene oxide (in the case of Chinese hamster ovary cells from 44% to 11%, mouse 
hepatoma MH-22A cells, from 22% to 3%). Raman imaging results of graphene 
oxide intracellular distribution in the cells suggest that the viability of MH-22A cells 
was decreased because a larger volume of graphene oxide was accumulated in these 
cells in comparison with Chinese hamster ovary cells.  
8. It was found that the functionalised graphene oxide with doxorubicin 
strengthens the effect of doxorubicin, as an anticancer drug. It was revealed that a 
statistically significant result, the viability of MH-22A cells, was approx. 20% lower 
than using doxorubicin separately (from 57% to 79%, respectively).  
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